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Introduction: Eating disorders (EDs) have increased globally in women of childbearing
age, related to the concern for body shape promoted in industrialized countries.
Pregnancy may exacerbate a previous ED or conversely may be a chance for improving
eating patterns due to the mother’s concern for the unborn baby. EDs may impact
pregnancy evolution and increase the risk of adverse outcomes such as miscarriage,
preterm delivery, poor fetal growth, or malformations, but the knowledge on this topic
is limited.
Methods: We performed a systematic review of studies on humans in order to clarify
the mechanisms underpinning the adverse pregnancy outcomes in patients with EDs.
Results: Although unfavorable fetal development could be multifactorial, maternal
malnutrition, altered hormonal pathways, low pre-pregnancy body mass index, and
poor gestational weight gain, combined with maternal psychopathology and stress,
may impair the evolution of pregnancy. Environmental factors such as malnutrition or
substance of abuse may also induce epigenetic changes in the fetal epigenome, which
mark lifelong health concerns in offspring.
Conclusions: The precocious detection of dysfunctional eating behaviors in the
pre-pregnancy period and an early multidisciplinary approach comprised of nutritional
support, psychotherapeutic techniques, and the use of psychotropics if necessary, would
prevent lifelong morbidity for both mother and fetus. Further prospective studies with
large sample sizes are needed in order to design a structured intervention during every
stage of pregnancy and in the postpartum period.
Keywords: eating disorders, anorexia nervosa, bulimia nervosa, binge eating disorders, pregnancy, fetal
outcomes, epigenetics, maternal psychopathology
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INTRODUCTION
Pregnancy is an exceptional condition that implicates intense
psychological and biological transformations, which may change
the perception of body shape, as well as influence modifications
in eating patterns. Pregnancy therefore represents a period of
increased weakness that triggers or aggravates symptoms of
problematic eating behaviors (1).
According to the Diagnostic and Statistical Manual of
Mental Disorders Fifth edition (DSM-V), Eating Disorders
(EDs) are “disturbances in eating behavior that result in altered
consumption of food and that significantly impair physical
health and psychosocial functioning” (2). Anorexia Nervosa
(AN) is characterized by a restriction of energy intake, leading
to significant weight loss, intense anxiety around gaining weight,
and a distorted perception of body weight and shape, associated
with perfectionism and overcontrol. Bulimia Nervosa (BN) is
associated with recurrent episodes of binge eating (eating a
great amount of food in a discrete period of time with a sense
of lack of control over eating and impulsivity), accompanied
by inappropriate compensatory habits such as self-induced
vomiting, abuse of laxatives or diuretics, and/or excessive
exercise. Binge-eating disorder (BED) is defined by recurrent
episodes of binge eating more rapidly than normal, which are
followed by feeling uncomfortable, disgusted, depressed, or guilty
as a result, however it is not associated with compensatory
behaviors to prevent weight gain. Other Specified Feeding of
Eating Disorders (OSFED) or Eating Disorders Not Otherwise
Specified (EDNOS) refer to heterogeneous symptoms of feeding
or ED resulting in a clinically significant problem that does
not meet the full criteria of others disorders (2). Patients with
chronic EDs often change between types of EDs (most commonly
between AN and BN).
EDs are common in women of reproductive age. The
prevalence of AN is an estimated 7 per 1,000 in the UK, with
more incidence in adolescent girls and young women. BN is
more frequent and affects older age groups, with a prevalence
of 0.5–1% in women of reproductive age (3). Atypical EDs are
probably more common but the literature about their prevalence
is scarce. According to the American Association of EDs, at
least 0.9% of American women suffer from AN, 1.5% from
BN, and 2.8% from BED in their lifetime (4). In Europe,
AN is reported at 1–4%, BN at 1–2%, BED at 1–4%, and
subthreshold eating disorders at 2–3% of women (5). Some recent
epidemiological studies estimate that the percentage of EDs has
increased over the last years to∼5–10% of women of childbearing
age (6).
The prevalence of EDs has been estimated at up to 7.5% in
pregnant women (7). The incidence of EDs in the Norwegian
Mother and Child Cohort was about 5%, where they found high
incidence of BED in particular (8). In Italy the prevalence of AN,
BN, and purging disorders during gestation was valued at up
to 5.5% (9). A study conducted on pregnant Brazil population
showed a prevalence of 17.3% of binge eating patterns associated
with anxiety and mood liability (10).
Pregnancy and the postpartum period are related to
variations in eating patterns such as overeating, strong rejection
of specific foods or drinks, changes in taste perception,
and women experience major body changes unseen since
adolescence, which may trigger an ED in otherwise healthy
pregnant patients (11, 12). Our culture which promotes
slimness, weight concern and dissatisfaction with gaining
weight, might lead to more dysfunctional eating attitudes (13,
14), because pregnant women may feel stressed and anxious
over their changing body shape (15–17). In addition, the
adaptive neuroendocrine modifications during gestation may
alter brain function, impairing metabolism, appetite regulation,
and mood (18).
Nevertheless, for most women ED symptoms tend to
reduce during pregnancy because of the concern for the
fetus, however this transient improvement of symptoms may
revert in the postpartum period (19). A retrospective study
reported that the prevalence of EDs was 11.5% from 3 to
7 months post-partum, with the most incidence in younger
women (20), and a longitudinal study found that 12.8% of
postpartum mothers suffered from a clinical eating disorder
(21). This underlines that the postnatal period represents a
vulnerable time for the exacerbation of disordered eating,
probably due to anxiety about the postpartum body shape
and to the frustration and stress of taking care of demanding
infants, especially if there is not enough marital support (22).
Furthermore, a longitudinal case-control study underlined that
women with a recent ED had a higher rate of concern
about weight gain and more loss of control over eating
during pregnancy, and women with a past ED presented
more compensatory behaviors than controls (23). In cross-
sectional data in a Norwegian pregnant population, the incidence
of BED during gestation was linked to social problems,
symptoms of anxiety and depression, low life satisfaction, history
of sexual and physical abuse, and smoking. Apprehension
about pregnancy-related weight gain was the variable most
strongly related to the onset of BED (24). Dysfunctional
eating patterns may also reflect stress-response mechanisms
related to the activation of Hypothalamic-pituitary-adrenal
(HPA) axis and the corticotropin-releasing hormone (CRH)
secretion which modulate food intake. Stress both stimulates the
proopiomelanocortin (POMC) neurons eliciting anorexic signals
and induces suppression of NPY secretion, declining its central
orexigenic and anxiolytic actions (25).
Additionally, there are cultural influences that may trigger
an ED during pregnancy. For example, food restriction during
pregnancy is common in Chinese women, owing to the belief
that this may protect the child and avoid complications such as
miscarriage, stillbirth, death of the mother, and imperfections in
newborns. For this reason, traditional women avoid cold foods
or wet-hot foods, which are considered bad for the baby. These
restrictions are often associated with symptoms of depression
(26). Recent evidence showed that maternal disordered eating
behaviors impact the course of pregnancy and fetal development.
Updated reviews of the literature highlighted that the major
obstetric and gynecologic complications were infertility, high rate
of miscarriage, poor nutrition during pregnancy, hyperemesis
gravidarum, cesarean section, preterm delivery, and postpartum
depression (27–30). The most described detrimental effects
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on fetal development were fetal growth delay, small for
gestational age babies and small head circumference, low
Apgar score and an increased risk of perinatal mortality
(27–30).
Despite the risk of EDs for both mother and fetus,
the recognition of EDs during pregnancy is considered a
challenge. ED is a multifactorial pathology, and it may be
linked to predisposing factors including genetics, familiar and
social dysfunction, mental illness such as Obsessive-Compulsive
Personality Disorder (in AN) and Borderline Personality
Disorder (in BN), or psychiatric disorders such as anxiety,
depression, and substance abuse (31). There are not specific
biochemical markers or precise instruments for the diagnosis
of EDs in pregnant population, but standardized screening
method, and questionnaires are available, whichmay differentiate
normative dieting and eating concern from more dysfunctional
behaviors (32, 33) (see Supplementary Material). Moreover, it
is difficult to recognize the onset of an ED, because women
often keep their condition secret (34). Stigmatizing attitudes
may contribute to feelings of shame and guilt that lead them
to hide their disorder and avoid help (35). On the other hand,
clinical symptoms during pregnancy may be masked due to
a reduction in clinical features or the presence of pregnancy
sickness and hyperemesis gravidarum (36). Nonetheless, it is
imperative to reach an early diagnosis in order to prevent long-
lasting effects on women of reproductive age and impaired fetal
outcomes (37). Clinicians should pay attention to warning signs
such as lack of weight gain in consecutive visits during the
second trimester, hyperemesis gravidarum that persists more
than 20 weeks, or previous history of ED, depression, or
dieting (38).
The purpose of this systematic review was to provide
an update on the existing studies in humans focused on
the effects of EDs during pregnancy on maternal and
fetal outcomes. Specifically, our aim was to increase our
knowledge on the topic of EDs during pregnancy, in
order to highlight the importance of early prevention of
these disturbances. We also focused on the effect of these
dietary patterns have on fetal development and maternal
psychopathology, to find a target therapy that could avoid
fetal complications.
METHODS
The manuscripts included in this systematic review mainly
concern EDs such as AN, BN, BED, and ENDOS. We did
not assess studies about other types of EDs. Studies were
screened based on PRISMA methodology, by searching titles
and abstracts in the following electronic databases: SCOPUS,
MEDLINE//PubMed, and Cochrane. The research was based
on the combination of the following descriptors: eating
disorders, anorexia nervosa, bulimia nervosa, binge eating
disorders, pregnancy outcomes, fetal development, small for
gestational age, epigenetics, preterm delivery, malformations,
food intake, eating patterns, fertility, gestational weight
gain, postpartum depression, maternal psychopathology, and
breastfeeding/human milk. Boolean terms AND/OR/XOR were
combined in the search.
Inclusion criteria were: the period covered from January 1 of
2000 to May 31, 2020, the presence of selected descriptors in the
title of the papers or as keywords, only articles written in English
language and only studies performed in humans, excluding books
and documents as well as all references which results were
based on animal models. Original manuscripts were selected by
screening titles and abstracts, creating a reference list of relevant
papers for the topics explored in this review. Of note, pre-
conception period was also included. Two investigators (A.-F.V.
and S.G.) conducted each stage of the studies selection, deleted
duplicate inputs and evaluated the quality of the studies. All
data were extracted by one investigator (S.G.) and cross-checked
by a second investigator (A.-F.V.). In case of discrepancies in
the selected studies, we opted for reconciliation through team
discussion. The following variables were also explored: study
characteristics including study design (case–control, review,
longitudinal cohort, and cross-sectional), sample size, country,
characteristics of participant population (number of cases,
diagnostic criteria for EDs, hospitalized patients, type of EDs)
and results (including strengths, limitations, conclusions, and
possible biases). The quality of controlled studies (randomized,
non-randomized, before-after) was critically appraised using the
Cochrane Collaboration’s Risk of Bias Tool (39).
The initial search identified a total of 249 papers once the
inclusion and exclusion criteria were applied. After reviewing
the abstract 126 studies were not selected because they were
out of the scope of this review (eating disorders, pregnancy
and fetal outcomes) and we also discarded 11 duplicate studies.
Thirty records were selected through other sources by their
relevance in the field. This resulted in 142 published studies.
Additionally, for epigenetics section, the search was “(eating
disorders or anorexia nervosa or bulimia nervosa or binge eating
disorders) and (pregnancy or fetal outcome or preterm) and
epigenetics” obtaining 25 results. Twenty articles were selected
and 5 additional papers were included from other sources by
their relevance in this issue. In the case of breastfeeding section,
the terms used were “(eating disorders or anorexia nervosa or
bulimia nervosa or binge eating disorders) and (pregnancy or
fetal outcome or preterm) and breastfeeding” showing 42 results.
Thirty studies were finally selected. Both sections were performed
following the same inclusion and exclusion criteria. Finally, 197
studies were selected to perform this review.
We expected an important bias due to the heterogeneous
results observed in the literature selected by the different
populations compared, the distinct health condition of them,
the lack of randomized trials in pregnant women with EDs
the use of questionnaires to detect nutritional deficits and
psychological alterations as well as the small sample size
observed in some studies. Otherwise Table S1 included the
American Dietetic Association Guidelines for pregnancy and
the International Guidelines for the management of EDs during
pregnancy to contextualize the nutritional requirements during
this period. Moreover, scientific papers related to the nutritional
and hormonal status of pregnant women were also included to
evaluate possible detrimental effects on fetal development.
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REVIEW
Periconceptional Period in Women With
EDs
Women with EDs are reported to have menstrual irregularity,
problems with sexuality linked to a conflicted relationship with
their body, decreased libido, and high sexual anxiety (40, 41).
This can lead to insufficient use of contraception methods with
a consequent unplanned pregnancy. In a prospective pregnancy
cohort study, 50% of women with AN reported unplanned
pregnancy when compared to a control group without EDs (42).
An unplanned pregnancy may add risk to fetal development due
to poor prenatal care, such as drinking alcohol, failing in balanced
nutrition, or delaying the intake of prenatal vitamins. Moreover,
unintentional pregnancy may exacerbate contrasting feelings in
women, such as excitement yet depression and anxiety, when
discovering their pregnant status.
There is a critical level of accumulated energy or fat mass
that is essential for maintaining regular menstruation. EDs
may affect fertility and menstruation because malnutrition
and weight loss may alter hormonal status. Reduced levels
of luteinizing hormone (LH) and follicle-stimulating hormone
(FSH) suggest hypothalamic and pituitary dysfunction, which
often lead to anovulation and amenorrhea. Sex hormones interact
with neurotransmitters to achieve central control of appetite and
energy balance, so in EDs there is a deregulation of appetite
mechanisms (43). Women with AN may experience a drop in
levels of leptin, a hormone that inhibits appetite and it is linked
to energy homeostasis. This fall in leptin is associated with low
caloric intake and with low fat mass, resulting in the reduction
of the pulsatile release of gonadotropin-releasing-hormone
(GnRH). All these hormonal pathways provoke dysfunction
in ovulation, menstruation, and bone growth (44). Moreover,
it has been reported that women with BN may be affected
by hyperandrogenism and polycystic ovary syndrome (PCOS),
a common cause of infertility, characterized by higher levels
of circulating androgens. Testosterone is known to stimulate
appetite and has been linked to altered impulse control and
depression, so patients with PCOS exhibit a deregulation of
appetite that may exacerbate bulimic symptoms (45). In addition,
elevated ghrelin levels observed in patients with EDs may
produce continuing inhibition of the hypothalamic-pituitary-
ovarian axis and amenorrhea in spite of normal body fat and
leptin levels. Low insulin status is also linked to amenorrhea,
related to hypothalamic sensors of insulin levels. In patients
with EDs, the activation of the HPA axis starts as a result
of a stress reaction, leading to increased levels of CRH and
cortisol, and failure of the circadian rhythm of cortisol. Through
metabolic pathways, these hormones interact with the GnRH
directly or through neuropeptide mediators (neuropeptide Y or
kisspeptin). The final result of these metabolic signals in patients
with EDs, is the inhibition of the normal pulsatile GnRH, low
levels of LH, FSH, estradiol and small ovaries, the main causes of
infertility (46).
There is little data about the prevalence of EDs in women
affected by fertility problems. The prevalence of ovulatory
disturbances is considerably higher in females with severe EDs
(47). A recent longitudinal study conducted on women who
started infertility treatment, found that the prevalence of EDs
was 20.7% and the most prevalent EDs were AN and BED
(48). In the longitudinal Avon study cohort of Parents and
Children (ALSPAC) (49), the EDs groups with AN or AN+BN
participants, took no longer than 12 months to conceive, but
they delayed more than the general population (>6 months),
and were more likely to conceive the current pregnancy with
fertility treatment. This study underlines that women with AN,
or AN+BN experienced conception problems without meeting
the criteria for infertility (defined as inability to conceive for
more than 12 months). This group included women with the
lowest preconception BMI, which may explain the difficulty in
conceiving. The authors concluded that fertility was affected in
the EDs group but not considerably impaired. The limitation
of this study is that the classification of EDs was made on the
basis of self-reporting. A recent longitudinal population-based
cohort study performed in theNetherlands showed that EDs were
associated with increased odds of receiving fertility treatment
and twin births, regardless of pre-pregnancy BMI (50). Another
study showed that female patients with EDs recruited at Helsinki
University Central Hospital had impaired reproductive health
with the lowest pregnancy rate in patients with AN and a high
rate of miscarriage in patients affected by BED (51).
Preconception Nutritional Profile in
Adolescents and Women With EDs (See
Tables 1, 2)
Healthy BMI prior to pregnancy is considered between 18.5 and
25 kg/m2 and current evidence suggests that poor or excessive
gestational weight gain (GWG) are risk factors for perinatal
complications. According to the Institute of Medicine(IOM)
there are reference tables for correct GWG during pregnancy (see
Table 1) (73–76).
Few studies reported micronutrients status in patients with
EDs with controversial results, because the majority evaluated
dietary intake based on questionnaire reports and others assessed
plasma levels. Cross-sectional and longitudinal case-control
studies conducted on women of childbearing age with a history of
AN determined a predominance of low intake of micronutrients
like vitamin D, calcium, phosphorus, folate, sodium, magnesium,
zinc, and copper. With regard to vitamin B12, results about
the intake were contradictory: one study showed low intake
in patients with AN characterized by high rate of vegetarians,
but others did not find differences in intake when compared
with the control group (53, 69). The limitations of these studies
were the small sample sizes and the estimation of food portions,
which were based on food questionnaire, since patients may
underestimate or overestimate their nutrient intake. The high
rate of vegetarianism among EDs women and consequently the
lack of intake of meat and fish, is linked to a low source of iodine,
iron, vitamins A, D, B12 and long chain omega-3 polyunsaturated
fatty acids (77).
Another cross-sectional study did not find differences in
dietary intake of minerals in adolescent girls with AN. In fact,
the authors described a great intake of vitamins due to higher
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TABLE 1 | IOM weight gain recommendations during pregnancy (52).







range of total weight (lb)
Recommended rates of GWG in
the 2nd and 3rd trimester (lb)
Mean range (lb/week)




Overweight 25–29.9 15–20 0.6 (0.5–0.7)
Obese ≥30 11–20 0.5 (0.4–0.6)
supplement consumption. However, these results were described
in community-dwelling girls with AN, included in interventional
and support strategies (55).
A review of literature conducted by Setnick (58), reported
blood electrolyte disturbances in patients with EDs due to
purging behaviors. Moreover, the author showed inadequate
calcium intake, iron deficiency anemia, and zinc deficiency
because patients restricted meat and practiced heavy exercise
with consequent impaired absorption of elements. In contrast,
vitamin A could be elevated in serum due to inadequate intake
of other nutrients essential for vitamin A metabolism like dietary
fats. Patients with EDs were found to have low ingestion of
Vitamin B1, B2, and B6 because of restrictive eating patterns
associated with alcohol consumption. Plasma deficiencies of
Vitamin B12 and folic acid were also present in patients with
EDs due to low intake, as judged by elevated plasma levels
of homocysteine. Hematological deficiencies such as anemia,
leucopenia, and thrombocytopenia are often present in patients
with severe AN (54, 64).
Adolescence is a critical period for bone mass content, which
is regulated by hormonal pathways. Estrogen and androgen
release are decreased and cortisol increases in patients with
EDs. Furthermore, conversion of free T3 and production of
insulin-like growth factor-1 (IGF-1), are reduced. Such hormonal
imbalances joined with nutritional deficiencies in vitamin D and
calcium, decrease bone establishment, so 50% of adolescents with
EDs displayed low mineral density (78). Young women affected
by EDs were found to be vitamin D deficient (<50 nmol/L) and
vitamin D levels predict low bone mineral density (BMD) in the
lumbar spine, femoral neck and total hip. Weight gain was the
most important factor in the improvement of BMD (62, 66). AN
is associated with a high risk of osteoporosis and osteoporotic
fractures at a young age (68). Conversely, Carlsson et al. (72)
didn’t find any differences in total and free 25 (OH) vitamin D in
AN patients and healthy controls. A possible explanation could
be that AN patients have a lower amount of adipose tissue, and
vitamin D is a fat-soluble vitamin stored in fat tissue. If these
patients present a deficit in fat mass, adipose tissue can’t uptake
vitamin D, resulting in increased levels. Nevertheless, this study
was conducted in a specific population (Swedish), and vitamin
D supplements were not registered, so it is difficult to generalize
these results.
One of the most recent studies documenting nutritional status
in 153 young women with AN found at least one trace element
and one vitamin deficiencies in almost half of patients, the
most frequent were selenium, vitamin A and B9, suggesting that
micronutrient status is often disrupted in AN patients (71).
The Impact of EDs During Pregnancy on
Eating Patterns and Maternal Nutritional
Profile (See Table 2)
Weight management during pregnancy is imperative for the
health of offspring and it is linked to a balanced diet and to a
regular physical activity (see Table S1). The majority of studies
that report on eating behaviors in pregnant patients with EDs
have found a high rate of remission of symptoms related to image
concern, and decreased restrictive and purging attitudes (8, 19).
These changes might be related to a sense of responsibility for
fetal development, a different perception of their body during
pregnancy, and greater support from family and clinicians (79).
Other studies redact that pregnancy may trigger a relapse of EDs
symptoms (23). Moreover, pregnancy may promote a remission
of symptoms in patients with BN but it may generate the onset
or continuation in BED patients (17). A recent systematic review
showed that women with lifetime AN, BN, or AN+BN had
similar nutritional patterns and similar intake of supplements as
healthy women suggesting a remission of ED symptoms during
gestation. This data only found greater energy and fat intakes in
BED population (80).
A study conducted in a large UK general population cohort
(ALSPAC) (60) included 414 patients and 9,723 controls and
assessed eating patterns and nutrient intake in women with
lifetime EDs during the third trimester of gestation using the
Food Frequency Questionnaire (FFQ). The results showed that,
in general, dietary patterns during pregnancy in women with
EDs were similar to women from the general population. In
relation to energy, carbohydrate, fat, and protein intake, no
differences were found in the EDs group when compared to
the control group. Nevertheless, they highlight that women
with EDs consumed more soy products and plant-based food
than controls and defined themselves as vegetarians. Moreover,
women with AN and AN+BN showed high folate and potassium
consumption; women with AN+BN had a higher intake of
calcium, phosphorus, zinc, and vitamin C, and women with BN
had higher vitamin E ingestion. They did not observe differences
linked tomacronutrient consumption. Interestingly, womenwith
EDs consumed higher amounts of caffeine (>2,500 mg/week)





























TABLE 2 | Studies about the effects of eating disorders on maternal nutritional status: pre-conception period and pregnancy.
Author
(year)





(53) To evaluate the accuracy of
diet history compared to
observed food intake in








Diet history is accurate to
assess fat intake and
macronutrient composition




- No differences were found between reported intake and observed intake for macronutrient
composition, fat and energy in AN (1,602 ± 200 vs. 1,289 ± 150 Kcal, p < 0.05)
- Micronutrient intake by diet history was highly correlated with observed intake in patients
with AN (p < 0.05)
- Based on reported intake, 50% of AN failed to meet the RDA for vitamin D, calcium, folate,
vitamin B12, zinc, magnesium, and copper
- 50% of controls failed to meet the RDA for vitamin D, folate, calcium, magnesium, iron,
zinc, and copper
- No correlation was found between reported intake of macro and micronutrients and
energy in controls p < 0.05
Nova et al.
(2004)
(54) To assess the evolution of
serum biochemical
indicators of nutritional












- Transferrin levels at admission were lower in rAN patients than in controls (250.9 ± 54.9
vs. 285.9 ± 21.0, p < 0.05)
- Calcium and zinc showed significantly lower values in rAN when compared to the healthy
subjects (at admission, Calcium 8.85 ± 0.37 vs. 9.56 ± 0.25, p < 0.01)
- The mean serum level of phosphorus, calcium, zinc and iron in patients did not change
during the follow-up (repeated measures ANOVA p-values, range 0.105 vs. 0.366)
- Changes in ferritin and zinc showed significantly negative correlations with changes in
anthropometrical parameters (Zinc correlation range −0.62 to −0.73, p < 0.05)
Misra et al.
(2006)
(55) To compare nutrient intakes







Girls with AN hadlower fat
and higher fiber intakes than
do healthy adolescents,
which results in lower
calorie intakes
- Dietary intakes of calcium, phosphorus, iron, zinc, copper, selenium, and sodium did not
differ significantly between the girls with AN, and the control subjects (1,169 ± 88 vs.
981 ± 8; 1,333 ± 82 vs. 1,216 ± 77; 17.4 ± 1.4 vs. 15.0 ± 0.9; 10.9 ± 1.1 vs. 9.3
± 0.5; 1.2 ± 0.1 vs. 1.1 ± 0.1; 92.7 ± 6.9 vs. 101.9 ± 6.0; 2,879 ± 220 vs. 2,997 ±
137, respectively)
- Greater intakes of vitamins A, D, and K and of most of the B vitamins in the AN group,
because of greater supplement use (13,823 ± 1,405 vs. 7,133 ± 917, p < 0.001; 11.3
± 1.3 vs. 6.7 ± 0.9, p < 0.01; 167.5 ± 47.5 vs. 66.9 ± 7.1, p < 0.05, respectively)
Micali et al.
(2007)
(23) To determine the impact of




Women with a recent ED
continued to have some ED
symptoms in pregnancy, but
fewer compared to before
pregnancy
Although at a lower level,
women with a past history
of ED also had ED
symptoms in pregnancy
- Women with a recent episode of ED dieted, used laxatives, reported self-induced
vomiting, and exercised more than other groups during pregnancy, non-obese and obese
controls (p < 0.05) with dieted OR = 5.1, 2.1–11.9, Used laxatives OR = 49.6, 16.1–
152.5; self-induced vomiting OR = 51.9, 26.4–102.1, and high exercice OR = 1.8, 1.0–
3.3. -Compared to non-obese controls, they were also more likely to report ED cognitions
in pregnancy and their weight and shape concern scores remained high during pregnancy
(report a strong desire to lose weight OR 6.1, 3.4–10.7, p < 0.001, they felt they had put
on too much weight OR 2.5, 1.3–4.8, p < 0.01; they felt a loss of control over eating.
OR 4.6, 2.5–8.6, p < 0.001 and felt a high concern about weight gain OR 2.4, 1.2–4.7,
p < 0.01)
- Compared to non-obese controls, Women with past ED were also more likely than
controls to have some ED behaviors and/or concerns about weight gain (report a strong
desire to lose weight OR 1.6, 1.3–2.0, p < 0.001, they felt they had put on too much
weight OR 1.4, 1.1–1.7, p < 0.01; they felt a loss of control over eating. OR 1.3,














































































TABLE 2 | Continued
Author
(year)









Mother and Child Cohort
Study (MoBa)
n = 41,157
Pregnancy appears to be a
catalyst for remission of
some eating disorders, but
also a vulnerability window
for the new onset of broadly
defined BED especially in
economically disadvantaged
individuals
- Proportions of individuals remitting during pregnancy were 78% (EDNOSP), 40% (BN
purging), 39% (BED), 34% (BN any type), 29% (BN non-purging type). Additional
















ED examination for restraint, shape concerns, weight concerns, binge eating, and purging
diminished from prepartum to intrapartum, but returned to approximately baseline levels
postpartum.
Frequencies log-transformed mean(SD), Prepartum/intrapartum/postpartum
Restraint 1.94 (0.26), 1.20 (0.24), 1.94 (0.26), p < 0.0001
Shape concern 2.68 (0.24), 2.21 (0.22), 2.76 (0.24), p < 0.0001
Weight Concerns 2.65 (0.24), 1.77 (0.22), 2.70 (0.24), p < 0.0001
Binge eating 0.03 (0.15), −0.36 (0.14), −0.15 (0.13), p = 0.0086
Purge frequency 0.04 (0.17), −0.03 (0.15), −0.10 (0.16), p = 0.0094
Siega-Riz
et al. (2008)
(56) To examine the nutrient and
food group intake of women
with EDs during pregnancy
Longitudinal cohort.
Cross-sectional Norwegian
Mother and Child Cohort
Study (MoBa)
Total n = 37,307




- Higher intakes of total energy, total mono-saturated and saturated fat, and lower intakes
of folate, potassium, and vitamin C in women with BED before and during pregnancy
compared to controls (p < 0.02). Mean ± SD Total energy 2.459 ± 30.2 vs. 2348 ±
4.6, Total MS 27.8 ± 0.4 vs. 25.6 ± 0.1, Total Saturated fat 34.2 ± 0.5 vs. 31.3 ±
0.1, respectively Folate 268.9 ± 3.8 vs. 273.4 ± 0.7, Potassium 4008.1 ± 49 vs. 4018.6
± 7.6, Vitamin C 155.5 ± 3.7 vs. 167.5 ± 0.6, respectively
- Higher total energy and saturated fat intake in women with incident BED compared to
controls (p = 0.01) Total energy 2544.1 ± 41.2 vs. 2348.3 ± 4.6, Saturated fat intake
34.9 ± 0.6 vs. 31.3 ± 0.1, respectively
Swann et al.
(2009)
(57) To explore attitudes toward
weight gain during




attitudes and actual GWG
Prospective
population-based
Norwegian mother and child
cohort study (MoBa)
n = 35,929








- The presence of an eating disorder was associated with greater worry over gestational
weight gain AN Very Worried OR (95% CI) 49 (17–142), Somewhat worried OR 4 (95%
CI) (1–15) BN Very Worried OR 62(95% CI) (41–92), Somewhat worried OR(95% CI) 7 (4–
10) EDNOS-P Very Worried OR (95% CI) 80 (19–345), Somewhat worried OR (95% CI)
15 (3–65) BED Very Worried OR (95%CI) 7 (4–10), Somewhat worried OR (95%CI) 3 (3–4)
- Women with BED who reported greater worry also experienced higher weight gains




(58) To assess the findings
reported to date regarding
micronutrient deficiencies
and supplementation for
patients with anorexia and
bulimia
Narrative review Patiens with ED showed
micronutrients deficiencies
due to low intake
Patients with EDs were found to have electrolyte disturbances, low levels of calcium, iron,















































































TABLE 2 | Continued
Author
(year)





(59) To examine the amount of
weight of women with
eating disorders AN, BN
and BED gained during
pregnancy and to evaluate
the adequacy of total weight
gain
Cross-sectional Norwegian
Mother and Child Cohort
Study
n = 35,148
Women with AN had a
lower risk of gaining weight
inadequately while women
with BN and BED were
more likely to gain
excessively weight during
pregnancy
- Mean gestational weight gain for the entire sample was 2.5 (SD 0.02) kg at 17.0–20.1
weeks gestation, 9.3 (SD 0.03) kg at 27.4–29.7 weeks gestation and 15.0 (SD 0.03) kg
at delivery.
- Women with BN and BED gained significantly more weight on average than those with
no EDs at each time point. BN 3.9 (0.3) vs. 2.5 (0.02), 10.9 (0.3) vs. 9.3 (0.03), and 16.6
(0.4) vs. 14.9 (0.03), at each respective time point, p < 0.001 BED 3.2 (0.1) vs. 2.5
(0.02), 10.2 (0.2) vs. 9.3 (0.03), and 16.6 (0.2) vs. 14.9 (0.03), at each respective time
point, p < 0.001 -Women with AN had a lower risk AOR 5 0.65 (0.24, 1.72) of gaining
inadequately while women with BN and BED were more likely to gain excessively, AOR 5
1.09 (1.01, 1.18) and 1.11 (1.08, 1.14), respectively
Micali et al.
(2012)
(60) To investigate the frequency
of consumption of various
food groups and quality of
intake (macronutrient





AN = BN = 77
Controls = 9,723
Despite some differences in
food group consumption,
women with lifetime ED had
similar patterns of nutrient
intake than healthy controls
- Women with lifetime ED scored higher on the “vegetarian” dietary pattern (OR 2.8, CI
95% 2.1–3.8)
- No deficiencies in mineral and vitamin intake were evident in lifetime ED, although small
differences were observed in macronutrient intakes across groups. All index groups had
higher intakes of Mg and Se; women with AN and AN+BN of Fe and K and women with
AN+BN of P, Ca, and Zn compared to unexposed women A lower sugar and non-milk
extrinsic sugar and a higher polyinsaturated fat intake in women with lifetime AN and
AN+BN. A higher fiber intake was also observed in women with lifetime AN, BN, and
AN+BN. AN increased the risk for a high (>2,500 g/week) caffeine consumption in
pregnancy (OR 2.6, 95% CI 1.4–4.8)
Micali et al.
(2012)
(61) To investigate adverse
perinatal outcomes and
GWG trajectories in women
with lifetime (current/past)








Maternal lifetime ED is
associated with few adverse
perinatal outcomes.
Differential GWG patterns in





- Maternal AN was positively associated with suspected fetal distress after adjusting for
confounders OR 1.8; 95% CI 1.0–3.1, p < 0.05. No differences were found in mean
birthweight, prevalence of a small-for-gestational-age, or premature birth. AN vs. BN vs.
AN+BN vs. unexposed BW 3.481 g (480), 3,468 (575), 3,465 (586) vs. 3,439 (546) 0.8
vs. 4 vs. 2.1 vs. 3.5% 3.2 vs. 3.5 vs. 7.8 vs. 4.3% -Relative to unexposed women,
women with AN had on average, a lower body weight regression coefficient −0.05 (95%
CI −0.08 to −0.1) but a higher rate of weight gain, 0.07%, whereas women with BN had
a higher body weight (regression coefficient 0.0007, 95% CI 0.00002–0.001) but a lower
rate of weight gain (regression coefficient −0.0007, 95% CI −0.001 to −0.0001)
Velickovic
et al. (2013)
(62) To investigate association of
vitamin D with BMD and




Low vitamin D and low BMI
are associated with low
BMD in EDs patients.
Vitamin D measurement is
appropriate in these patients
- 18% prevalence of vitamin D deficiency below 50 nmol/L
- Association between vitamin D and BMD T-score at the lumbar spine p = 0.029
(B = 0.206, 95% CI 0.120–0.293), femoral neck (p < 0.001) (B = 0.133, 95% CI
0.037–0.229) and total hip (p = 0.001) (B = 0.156, 95% CI 0.070–0.242)
- No relation between vitamin D and BMI (B = −1.451, 95% CI −4.096–1.193)
Coker et al.
(2013)
(63) To examines changes in
BMI and qualityof life related
to eating disorders (QOLED)
prior to, during and after
pregnancyin both women
with and without eating
disorders
Longitudinal ED = 19
Controls = 159
Australia
Pregnancy is not associated
with recovery from ED
The women with ED had significantly lower BMIs before, during and after pregnancy than
non-ED. Mean difference (MD) and (SD) for all time points: pre-pregnancy 2.09 (0.86,
p = 0.011), 1st trimester 2.12 (0.86, p = 0.023), 2nd trimester 2.37 (1.08, p = 0.043),
third trimester 2.79 (0.94, p = 0.007), at 3 months 3.27 (0.71, p < 0.001), at 6 months
2.92 (0.74, p < 0.001), at 12 months after delivery 3.67 (0.67, p < 0.001). Both women
with and without ED had significant weight gain in the second (ED p = 0.01 and non-ED
p < 0.001) and third trimesters (ED p = 0.001 and non-ED p < 0.001) compared
with pre-pregnancy. There were significant interactions between stage of pregnancy and
ED status on global QOLED scores (Wald X2 = 25.40; df = 6, p < 0.001). These scores
improved significantly during second (mean 8.19; SD 4.36, p = 0.017) and third trimesters
(mean 8.80; SD 4.67, p = 0.033) compared with pre-pregnancy but varied after
pregnancy, particularly among women with eatingdisorders. The QOLED scores for
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(64) Determine the prevalence of
hematologic abnormalities





are often present in patients
with severe AN but resolves
with nutritional rehabilitation
- 83% of patients were anemic with only 3 (6%) having iron deficiency
- 79% were leukopenic, 29% were neutropenic, 25% were thrombocytopenic, and 17%
of patients developed thrombocytosis during their hospitalization
Zerwas et al.
(2014)
(65) To examine gestational and
postpartum weight
trajectories in mothers with
and without EDs in the
Norwegian Mother and








Mothers with AN, BN,
EDNOS and BED gained
weight more quickly during
pregnancy, and lost weight




-Mothers with AN, BN, BED, and EDNOS had greater increases in BMI during pregnancy
and greater decreases in BMI over the first 6 months postpartum
- Women with AN shifted from the underweight BMI range before pregnancy to the




(8) To validate previously
published rates of
remission, continuation, and
incidence of broadly defined
eating disorders during
pregnancy
Summary of 19 studies
based on the MoBa study
Population-based
pregnancy cohort
EDs during pregnancy were
relatively common,
occurring in nearly 1 in every
20 women, although almost
all were cases of BED.
Pregnancy was a window of
remission from BN but a
window of vulnerability for
onset and continuation of
BED
Pre-pregnancy prevalence estimates in the “validation sample” were 0–1% for AN, 1% for
BN 3.3% for BED and 0.1% for purging disorder (EDNOS-P)
Gatti (2015) (66) To determine the prevalence
of vitamin D deficiency in
untreated patients with AN,






There is an association
between vitamin D and hip
BMD values.
Values of vitamin D above
20 ng/ml are recommended.
- 16.9% had 25OH vitamin D levels <12 ng/ml, 36% <20 ng/ml and 58.4% <30 ng/ml
- Patients with severe vitamin D deficiency (<12 ng/ml) presented BMD lower than that
measured in groups with values over 20 ng/ml. BMD femur neck (732 ± 134 vs. 858 ±
106) BMD total hip (721 ± 116 vs. 871 ± 85) (p < 0.001 for trend)
- PTH was higher and BMD of femoral neck and total hip were lower in patients with levels
of vitamin D <20 ng/ml compared to patients with Vit D >20. PTH 39.1 pg/ml ± 21.1 vs.
27.5 pg/ml ± 12.9 8 p < 0.01) BMD femoral neck 755 mg/cm3 ± 111 vs. 879 mg/cm3
± 104 (p < 0.001) BMD total hip 749 mg/cm3 ± 102 vs. 889 mg/cm3 ± 99 (p < 0.001)
Koubaa et al.
(2015)
(67) To investigate serum
biomarkers of nutrition and






Low maternal serum ferritin
in women with previous AN
may be of importance for
impaired memory capacity
in the offspring at 5 years of
age
- Serum levels of ferritin in the women with previous AN, but not in those with a history
of BN were significantly lower than in the controls (p < 0.01), and correlated strongly to
impaired memory function in their children
- Women with AN showed lower BMI and low GWG during pregnancy than BN or
control group. Maternal BMI Mean (SD) 18.9 ± 2.9 vs. 21 ± 3.0 (p < 0.001) AN vs. BN
and 18.9 ± 2.9 vs. 22.5 ± 2.8 (p < 0.01) AN vs. control group Maternal weight gain
mean (SD) 10.0 ± 3.8Kg vs. 12.9 ± 3.8 (p < 0.01) AN vs. BN and 10.0 ± 3.8Kg vs.
12.2 ± 2.7 (p < 0.01) AN vs. control group
Jagielska
(2016)





Narrative Review AN has been associated
with a high risk of
osteoporosis and
osteoporotic fractures at a
young age. Further studies
are needed to establish a
standardized treatment for
osteoporosis in AN women
- BMD values for osteopenia and osteoporosis were found, respectively, in 35–98% and
13–50% in women with AN
- Densitometric assessment of BMD is recommended in all patients with AN and
amenorrhea ≥12 months
- Supplementation of vitamin D and adequate calcium intake are recommended
- Improvement of BMD is observed after estrogen replacement and medroxyprogesterone











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































than general population during pregnancy (81), probably due to
its stimulating properties and to the desire to inhibit appetite.
Siega-Riz et al. (56) conducted a cross-sectional study in a
large (n= 35,148) Norwegian Mother and Child Cohort (MoBa)
and investigated food group intake by FFQ in pregnant women
with BN and BED in the first half of pregnancy. Women with
BED showed greater intake of total energy and total mono-
saturated and saturated fat. As for micronutrient consumption,
a small difference was found in women with EDs compared with
controls. Furthermore, women with BED showed a lower intake
of folate, potassium, and vitamin C related to lower intake of fruit
and juices and a greater intake of fat (butter, margarines, and oils)
and milk dessert. BN patients exhibited a lower intake of fatty
meat but there was higher consumption of artificially sweetened
drinks among women with BN and BED. Women with active
BED also consumed more coffee than the control group in order
to suppress appetite and to increase energy waste. The higher
socio-economic status of such population may induce bias.
Nguyen et al. (70) investigated a diet quality score in pregnant
women with EDs and found a higher quality score in EDs group
after adjustment for socioeconomic and lifestyle factors. This
result has been observed probably because women with EDs had
a preference for food with health advantages (vegetables, skim
milk) so they provide themselves a healthy diet out of concern
about fetal development.
The strength of the studies described were the large
population-based prospective design. The main limitations
were related to self-reported ED history, because this may
underestimate the ED, and to the assessment of portion size by
FFQ, which is not precise.
In a recent longitudinal cohort study, Koubaa et al. (67)
investigated pregnant nulliparous non-smoking women with a
history of AN and/or BN vs. controls, analyzing biomarkers
of nutrition during early pregnancy. Women with AN showed
a higher prevalence of anemia, lower BMI, low GWG during
pregnancy when compared to BN and the control group.
Moreover, the authors found low plasma ferritin levels suggesting
depleted iron stores. During pregnancy, mild anemia is a normal
consequence of hemodilution and the requirement for iron
rises because of increased fetal necessity and transfer across the
placenta. Preconception iron stores determine the risk of iron
deficiency anemia, so patients with EDs are at a greater risk for
gestational anemia.
The main limitation of aforementioned studies is the lack of
distinction between recent or ancient ED which may influence
the nutritional profile of pregnant women with EDs.
Therefore, evidences support that pregnant women with
EDs show sufficient quality in their diet demonstrating an
improvement in ED symptoms during pregnancy. However,
the ED subgroups exhibit differences related to the relapse
of symptoms during pregnancy, micronutrient deficiencies
and iron deficiency anemia, regardless to their intake and
linked to malabsorption or impaired intestinal motility which
should be close monitored. The increased demand for nutrient
supply to maintain fetal growth might lead to the possible
risk of unbalanced nutrient transfer, if required diet has
not reached.
Frontiers in Pediatrics | www.frontiersin.org 10 September 2020 | Volume 8 | Article 587
Sebastiani et al. Eating Disorders During Gestation
The Impact of EDs During Pregnancy on
GWG (See Table 2)
Studies carried out in longitudinal cohorts in Norway and the
Netherlands exhibited higher and quicker GWG in women with
EDs compared to controls. Micali et al. (60) described that
women with AN had lower body weight but greater rates of
GWG, whereas women with BN had higher body weight but
lower rates of GWG.
Siega-Riz et al. (59) assessed GWG during pregnancy in the
Norwegian Mother and Child Cohort Study in a cross-sectional
approach. Authors demonstrated that women with AN had a
lower risk of gaining inadequate weight during pregnancy, while
women with BN and BED gained significantly more weight
than those without an ED. Similar results were obtained by
Zerwas et al. (65). These differences in GWG were linked to
their eating pathologies, which persisted during pregnancy albeit
more attenuate. Women with AN gained more weight than
would be expected, probably because they exhibited the lowest
pre-pregnancy weight, therefore evoking more concern for the
unborn baby and undergoing partial remission of deregulated
eating patterns. Gaining weight in women with ED might be
protective for the increased demand of the fetus and it is the
result of an improvement in ED behaviors and better control
over purging patterns. The main limitations of these studies were
the self-reported history of EDs and that GWG was based on
maternal self-report which may underestimate it and induce bias.
Moreover, large population samples included healthier patients
with EDs than hospitalized women, and less severe symptoms
were more likely to improve GWG.
Nonetheless, Koubaa et al. (82) found in a smaller sample, that
anorexic pregnant women had considerably lower weight gain
than controls (10.4 kg compared with 12.1 kg), demonstrating the
persistence of restricted eating patterns and relapse of disordered
eating during pregnancy. A possible explanation is that, in this
study, patients with AN showed higher pre-pregnancy BMI if
compared to the other studies, so the GWG was lower. On the
other hand, women with BED who reported greater concern
for GWG also experienced higher weight gain during pregnancy
(57). Another study conducted in a small sample of ED patients
found low GWG during every stage of pregnancy (63). This slow
velocity of GWG may be explained by the most severe clinical
manifestations in these samples of clinical patients with EDs,
producing harmful effects on pregnancy and fetal outcomes.
The Impact of EDs on Pregnancy
Outcomes (See Tables 3, 4)
Endocrine Manifestations
EDs women display low levels of GnRH and consequently
decreased levels of LH and FSH due to hypothalamic dysfunction.
Moreover, even if in normal pregnancy leptin levels increase
(104), low levels of leptin and peptide YY, both anorexic
hormones, and high levels of ghrelin, an orexigenic peptide,
have been described in women with EDs. The suppressed
gonadotropin secretion in AN is associated with low T3 levels
and low TSH, suggestive of a hypothalamic origin of suppressed
thyroid function. Cortisol and CRH levels have been found to
be elevated in women with AN and BN (105). GH levels are
increased while IGF-1 levels decreased, demonstrating a GH
resistant status as an adaptive mechanism to starvation. Most
studies have also found increased levels of adiponectin in AN,
which is inversely related to BMI and is associated with increased
insulin sensitivity seen in AN women (106). Easter et al. (98)
assessed HPA axis regulation in women with EDs. They observed
different patterns of circadian salivary cortisol in pregnant
patients, such as lowmorning cortisol levels, suggesting a blunted
response of cortisol during the day. A possible explanation may
be a decrease in HPA axis response due to a pre-gestational
prolonged period of hypercortisol exposure in women with EDs.
Moreover, this may be triggered by higher symptoms of anxiety
and stress during pregnancy. The strength of this data was the
longitudinal design and the inclusion of past and recent ED
women. The limitations included that AN and BN patients were
grouped together, the small sample size, and the lack of pre-
pregnancy cortisol assessment. Further less, as depression or
anxiety are multifactorial pathologies, it is difficult to establish a
correlation with cortisol levels.
Hormonal changes might play a role in the remission patterns
of EDs during gestation. It has been hypothesized that increased
production of dihydroepiandrosterone (DHEA) by the placenta
in patients with ANmay counteract the adverse effects of cortisol,
increasing the rate of remission during pregnancy (79).
Pregnancy Outcomes
Recent studies focused on pregnancy outcomes in women with
EDs showed controversial findings. The main studies on ED
population-based sample and clinical ED patients highlighted
an increase in spontaneous abortion, particularly with BN (88),
and also a high incidence of preterm delivery (42, 51, 83, 88,
89). These adverse outcomes may be promoted by multiple
variables such as stress, hormonal imbalance, low leptin levels
and conditions like PCOS. For example, low leptin levels have
been associated with the risk of miscarriage, preterm delivery,
and poor fetal growth (104).
The association between EDs and preterm delivery is
controversial, and it was found more strongly related to
hospitalized patients. Sollid et al. (85) designed a longitudinal
case-control study, comparing pregnant women with EDs with
healthy controls. They observed a higher risk of preterm delivery
and small for gestational age (SGA) babies in the women with
EDs but they analyzed more severe cases and they did not
differentiate between AN and BN. Bulik et al. (91) found a
higher rate of smoking, preterm delivery, and greater risk of
delivery induction only in patients with BED. Additionally, in
the BED population there was a higher risk to deliver a large
for gestational age (LGA) newborn and a higher rate of cesarean
section. Conversely BED women had lower rate of SGA probably
because they gained more GWG. It is important to mention that
the data was based on maternal self-report and this population
had good socioeconomic status. Pasternak et al. (92) performed a
retrospective study obtaining a higher rate of preterm delivery in
more severe diagnosed ED women. This finding was associated
with low pre-pregnancy BMI, low GWG, and higher rate of
fertility treatment in the ED group. They also found a greater rate





























TABLE 3 | Studies about the effects of eating disorders on pregnancy and fetal outcomes.
Author
(year)







(83) To assess the impact of eating disorders
(EDs: AN or BN) on pregnancy outcomes
and the impact of pregnancy on cognitive






therapeutic abortion and live
birth
High rate of therapeutic abortion in EDs population
Franko et al.
(2001)
(84) To report obstetrical outcomes in a group
of women with AN or BN
Prospective study
Pregnant women with
ED (AN and BN) n = 49
United States
Pregnant women with active
EDs appear to be at greater
risk for delivery by cesarean
section and for postpartum
depression
Pregnant women with EDs appear to be at greater risk for delivery by
cesarean section (41 vs. 12%) and for postpartum depression (45 vs.
29%).
Higher rate of birth defects (n = 3, 6.1%)
No differences in rates of prematurity, Apgar score, or infant birth weight
Park et al.
(2003)
(30) To review evidence in genetic factors,
pregnancy, the perinatal and postpartum
period, infancy, and the early years,
focusing on feeding and mealtimes,
general parenting functions and growth
Review ED pregnant women had
higher rate of miscarriages,
intra-uterine growth
restriction, low infant birth
weight, prematurity,
perinatal mortality, lower
Apgar score, and congenital
abnormalities
- AN with low pre-pregnancy weight and low GWG have been
associated with low infant birth weight, prematurity, perinatal mortality,
lower Apgar score, congenital abnormalities
- BN had a higher rate of miscarriages, intra-uterine growth restriction
and congenital malformation
- 5 possible mechanisms: genetic influences and gene-environment
interactions, parental eating psychopathology may impinge directly
on the child, disrupt general parenting functioning, learnt behavior,
discordant marital, and family relationship
Sollid et al.
(2004)
(85) To determine the association of an ED
diagnosed before pregnancy and a









ED pregnant women had a
higher rate of
low-birth-weight infant,
preterm delivery, and SGA
infants
- ED had Greater risk of Lower BW(OR, 2.2; 95% CI, 1.4–3.2), preterm
delivery (OR, 1.7; 95% CI, 1.1–2.6), SGA (OR, 1.8; 95% CI, 1.3–2.4)
- The risk of a low BW infant was twice as high in women with a previous
ED compared with women with no such disorder
- The risk of preterm delivery and a SGA infant was increased to 70%
-Not mention to BMI, very severe cases
Kouba et al.
(2005)
(82) To examine pregnancy and neonatal





Controls n = 68
Cases n = 49 (24 AN,
20 BN, 5
EDNOS) (Stockholm)
ED was associated to
higher incidence of SGA,
low birth weight, smaller
head circumference and
microcephaly
- SGA: 12 vs. 1%, p < 0.005 -Low birth weight (g): AN 3,210 ± 533 vs.
controls 3,516 ± 515, p < 0.05
- Head circumference (cm): AN 33.7 ± 1.6, BN 33.7 ± 1.0, vs. controls
35.2 ± 1.6, both p < 0.001
- Microcephaly: ED 8% vs. controls 0%, p < 0.005 -IUGR: ED 8% vs.
controls 0%, p = 0.07
- GA (weeks): ED 38.9 ± 1.8 vs. controls 39.2 ± 1.8, p = 0.043
Ekéus et al.
(2006)
(86) To examine birth outcomes and pregnancy






from hospital with a
diagnosisof AN vs.
primiparous with no AN
AN = 828,582
Controls = 827,582
Past history of AN was not
associated with negative
birth outcomes
- Mean birthweight (g): AN 3,387 vs. controls 3,431 g, p < 0.005.
Non-adjusted by sex and GA
- Small for gestational age (adjusted by sex and GA): no differences
- Main birth outcome measures in women with a history of AN were very
similar to the main population




(87) To review the adverse fetal, birth, and
maternal outcomes because of EDs. To
enhance standard assessment practice
and facilitate early intervention for the ED
patient




perinatal mortality, low birth
weight, and microcephaly
ED had a higher risk of intrauterine growth retardation, premature birth,
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(88) To assess the impact of active BN in










- Higher % of unplanned pregnancies
- Higher ORs for postnatal depression, miscarriage, and preterm
delivery were 2.8 (95% [CI], 1.2–6.2), 2.6 (95% CI, 1.2–5.6) and 3.3




(89) To determine whether women with a
history of eating disorders are at higher
risk of major adverse perinatal outcome
Longitudinal cohort
study (ALSPAC) UK
AN = 171, BN = 199,
AN+BN = 82
n = 10,636 unexposed
EDs had not an increased
rate of preterm delivery. BN
has been associated to
miscarriage and AN to
smaller birthweight babies
-BN was associated with miscarriage (relative risk ratio 2). Also, after
adjusted for lifetime smoking and alcohol use, age and parity (OR 1,4
((95% CI 1.1–2.0), p < 0.05) -AN had smaller babies (p < 0.05). It may
be mediated by lower pre-pregnancy BMI and to a lesser extent by
smoking in the second trimester of pregnancy. -Preterm delivery: AN
6.5%, BN 5.0%, AN+BN 4.9%, other psychiatric disorders 5.8%,
general population 4.8%. After controlling for ethnicity, maternal age,
and parity, Not differences between ED and general population. -Other
psychiatric disorders group had higher rates compared with the
general population (OR 1.3, 95% CI 1.0–1.8, p = 0.03). -No differences
in preterm delivery
Bridget (2008) (28) To review the effect of ED in pregnancy
and fetal outcomes
Review ED had been associated to
miscarriage, intrauterine
growth retardation,
premature birth, low birth
weight, and microcephaly
BN: miscarriage
AN: smaller babies, SGA, microcephaly, intrauterine growth restriction,




(90) To describe trends in the prevalence of
EDs among delivery hospitalizations in the
United States from 1994 to 2004 and to
compare hospital, demographic, and





Women with EDs are at






Delivery hospitalizations with an ED were significantly more likely than
those without an ED to have fetal growth restriction (odds ratio [OR]
9.08, 95% confidence interval [CI] 6.45–12.77), preterm labor (OR
2.78, 95% CI 2.10–3.69), anemia (OR 1.73, 95% CI 1.25–2.38),
genitourinary tract infections (OR 1.66, 95% CI 1.03–2.68), and labor
induction (OR 1.32, 95% CI 1.01–1.73)
Bulik et al.
(2009)
(91) To assess the association between EDs
(AN, BN, BED, EDNOS-P) and pregnancy
outcomes, controlled by confounding
variables (GA, maternal age, income,
education, parity, GWG)
To assess the association with secondary
outcomes (epidural, induction, placenta






in the 6-months prior to
or during pregnancy
(AN n = 35, BN
n = 304, BED
n = 1,812, EDNOS-P
n = 36) vs. referent
group (n = 33,742)
ED was not associated to
an increased rate of preterm
delivery.
BED is associated to a lower
risk of small for gestational
age babies and a higher risk
of large for gestational age
- BED adjusted by gestational age, maternal
age, income, education, and parity:
Lower risk of SGA OR 0.65 (95% CI: 0.52, 0.8) p < 0.01, and
after adjusting by smoking OR 0.63 (95% CI 0.51, 0.79) p < 0.01.
Large for gestational age OR 1.2 (95% CI: 1.1, 1.4), p = 0.02, and
after adjusting by smoking OR 1.2 (95% CI: 1.1, 1.4), p = 0.02
Preterm delivery OR 1.1 (95% IC: 0.92, 1.4) p = 0.65
- BED: higher% of LGA and c-section, lower% of SGA Not significant
results on AN (low prevalence n = 35)
- Preterm delivery adjusted by gestational age, maternal age, income,
education, and parity:
- AN: OR 0.63 (95% CI: 0.091, 4.3) p = 0.91
- BN: OR 0.78 (95% CI: 0.42, 1.4) p = 0.88
Bulik et al.
(2010)
(42) To assess unplanned pregnancy in AN
patients
MoBA cohort





RR 2.2 (95% CI, 1.64–2.72) of unintended pregnancies among AN
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(92) To assess whether EDs (AN, BN or
EDNOS) have an increased risk for
adverse obstetric and perinatal outcomes
Retrospective
Population-based
study ED = 122






risk of adverse pregnancy
outcomes
EDs patients were at risk of Low BW (OR 2.5, 95% CI 1.3–5.0),





(93) To compare pregnancy outcomes of
women with and without a history of AN
Prospective
case-control matched
(1 case: 5 controls) by
age, parity and year of
birth (1965–2007)
n = 804
Controls n = 670
women-−1,144 babies
Cases (AN) n = 134
women-−230 babies
Scotland
AN had a higher incidence
of IUGR
AN were at risk of IUGR: RR 1.54, 95% CI 1.11–2.13
Linna et al.
(2013)
(51) To assess how eating disorders are related
to reproductive health outcomes in a
representative patient population
Retrospective
EDs n = 2,257
Controls n = 9,028
Helsinki
EDs were associated with
increased risk of induced
abortion and miscarriage
compared to controls
-Women with BED were more than 3 times as likely to have a
miscarriage than controls [odds ratio (OR) 3.18; 95% confidence
interval (CI) 1.52–6.66]. -Women with atypical BN, defined as those
with one or more absent features of typical BN, were 44% more likely
to have a miscarriage than controls (OR 1.44; 95% CI 1.02–2.04)
Solmi et al.
(2014)
(94) To quantify the effect of maternal AN





AN was associated to





Systematic Review: AN and other Eds were associated with smaller
birthweight, differences found from −198 to −306g. Nevertheless, the
most of the studies don’t adjust by sex and gestational age; after this
adjustment, differences were smaller.
- Meta-analysis (active or past AN): a standardized mean difference of
weight: −0.19 kg (95% CI: −0.25, −0.15; P = 0.01)
- Good evidence of heterogeneity in the studies (χ² = 18.79,
P = 0.016; I² = 57.4%)
Linna et al.
(2014)
(95) To assess pregnancy, obstetric, and
perinatal health outcomes and






Controls n = 6,319
Cases n = 1,078
(AN = 302, BN = 724,
BED = 52)
Helsinki
AN and BN were associated
with lower birthweight. AN
was also associated with
IUGR, preterm delivery and
perinatal death. BN was
also associated to lower
Apgar score at 1min and
need of resuscitation.
BED was associated to
higher birthweight and to
large for gestational age.
- AN and BN had significantly lower BW babies (mean 3,302 g [SD 562],
adjusted p < 0.001 in AN, mean 3,464 g [563], adjusted p = 0.037
in BN, mean 3,520 g [539] in unexposed women) -BED had higher
weight babies (mean 3,812 g [519], adjusted p < 0.001). -AN was
significantly associated with anemia, slow fetal growth (OR 2.59, 95%
CI 1.43–4.71), small for gestational age (OR 2.20, 95% CI 1.23–
3.93) premature contractions, very premature birth (OR 4.59, 95% CI
1.25–16.87), and perinatal death (adjusted OR 4.06, 95% CI 1.15–
14.35). -BN was associated with premature contractions (OR 2.2,
95% CI 1.17–4.14), resuscitations of the neonate (OR 2.12, 95% CI
1.18–3.79), and a lowAPGAR score (OR 2.31, 95% CI 1.34–3.98)
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(67) To investigate serum biomarkers of
nutrition and stress in pregnant women
with a previous ED compared to controls
and in relation to head circumference and





Controls n = 59
Cases n = 37 (AN 20,
BN 17)
Sweden
EDs were associated to
smaller head circumference
even having the same
serum levels of free
thyroxine.
AN group had a positive
correlation between cortisol
and head circumference
- Maternal serum levels of free thyroxine were similar between groups
but correlated positively to reduced head circumference at birth of the
children in the BN group (r = 0.48, p < 0.05), and with the same
tendency in the AN group (r = 0.42, p = 0.07), but not in the controls
(r = 0.006)
- However, in the combined patient group, maternal free T4 correlated
positively to head circumference at birth (rp = 0.36, p < 0.05), as in
the BN group (rp = 0.48, p < 0.05), and with a similar tendency in the
AN group (rp = 0.42, p = 0.07),
- Cortisol levels were comparable between groups with the highest
mean value in the control group. In the AN group only, there was a
positive correlation between cortisol and head circumference of the
offspring at birth (rs = 0.49, p < 0.05)
- Head circumference (cm): AN 33.6 ± 1.6, BN 33.8 ± 0.88, control
35.2 ± 1.6, both p < 0.005
- Serum levels of IGF-I SD-score correlated positively with head
circumference of the offspring at birth in the patient group (rs = 0.38,




(96) To review the associations between
maternal undernutrition and obstetric risks
Literature review Maternal undernutrition is
associated to fetal growth
restriction
Low intake of dietary nutrients determines a fetal growth restriction,
may be due to an alteration in fetal hormones
Micali et al.
(2016)
(97) To investigate whether EDs are associated
with lower size at birth, symmetric growth
restriction, and preterm birth; and whether
pregnancy smoking explains the




Controls n = 76,724




EDs, specially AN, had a





and adverse fetal outcomes
- IUGR: AN and AN+ BN: OR 1.6 [95% CI 1.3–1.8]
- SGA: AN and AN+BN: OR 1.5 [95% CI 1.2–1.9). AN (15.5%) vs.
controls (10.4%): OR 2.90 (95% CI 1.98–4.26). Lower birthweight
was more associated with active AN than past AN, and it was lower
than controls
- Prematurity: Active AN + past AN: not differences on
prematurity rates. Active AN: double rates of prematurity than past
AN (7.51 vs. 4.11%). Active AN increased rates prematurity vs.




(27) To summarizes the literature on obstetric
and gynecologic complications associated
with EDs
Literature review No consistent informations
about fetal consequences of
pregnancy women with
eating disorders were found
Small samples studies report association between AN and increased
risk of miscarriage, preterm birth, low birth weight infants, SGA infants,
small head circumference, microcephaly, lower Apgar scores at 5min,
and greater risk of perinatal mortality. BN was associated with preterm
birth and lower Apgar scores at 1-min. Bigger samples studies report
contradictories results. Some studies affirm that women with ED (AN or
BN) have increased rates of fetal growth restriction, preterm delivery,
very premature birth, SGA, low birth weight, and perinatal death. While
others cohort studies from different places of the world have
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(98) To investigate HPA axis regulation in












infants also had a
heightened response to
stress
- Women with current ED (C-ED) had a significantly lower cortisol
decline throughout the day compared to controls, in both adjusted
and unadjusted analyses
- Lower cortisol decline among women with a current ED was
associated with higher levels of psychopathology during pregnancy
- Women’s cortisol awakening response, CRH and CRH-BP levels did
not differ across the three groups
- Infants’ stress response was significantly higher among those in the




(37) To study predictors of self-reported EDs
and associations with later health events
Prospective
case-control, cohort of
sisters of women with
breast cancer
Controls n = 38,264
EDs n = 726
Puerto-Rican women
EDs were associated with
higher rates of miscarriage
and induced abortion
Miscarriage: OR 1.19 (95% CI 1.09–1.35)
Induced abortion: OR 1.25 (95% CI 1.05–1.5)
Watson et al.
(2017)









Cases n = 5,295
(AN = 409,
BN = 1,451,
BED = 3,362, Purging
disorder = 73).
MoBa Cohort
EDs were associated with
fetal effects, affecting
specially the weight and the
gestational age
-AN was associated with: low birth weight (z-score): RR 0.74 (95% CI
0.68, 0.82). SGA: RR 1.54 (95% CI 1.09, 2.17). Postmature: RR 0.47
(95% CI 0.33; 0.67). -BN: Induced labor: RR 1.21 (95% CI 1.07, 1.36).
-BED: Birth weight (z-score): RR 1.07 (95% CI 1.05; 1.1). Length >




(29) To review obstetrical and fetal
consequences of ED and to present
specific clinical recommendations
Review EDs had negatives effects in
obstetrical and fetal
outcomes
Higher incidence of miscarriage and induced abortions, premature
birth, low birth weight, low Apgar scores, and perinatal death
Eik-nes et al.
(2018)
(100) To identify associations between a lifetime
ED (and obstetric outcomes.
Adjusted for parity, maternal age, marital
status, and year of delivery





EDs N = 532 vs.
unexposed n = 43,567
This study corroborates
available evidence on the
associations between
maternal ED and adverse
obstetric outcomes
AN had Higher rate of SGA (OR) 2.7, 95% CI 1.4–5.2.
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(101) To investigate several adverse birth
outcomes associated with Eds during
pregnancy: miscarriage, preterm birth
(PTB), low birth weight (LBW), SGA, and
LGA
To assess current ED and past ED
Narrative review (18
studies)
Of the 18 articles reviewed,
EDs were associated with
preterm birth and
small-forgestational-age
- Eds were associated with preterm birth in 5/14 (36%) and SGA in 5/8
(63%) studies
- AN increases the odds of a LBW baby, particularly when women enter
pregnancy with a low BMI
- BED is positively associated with having a LGA infant
- BN was associated with miscarriage when symptomatic
during pregnancy
- Having a current ED increases the risk for adverse birth outcomes
more than a past ED
Chan et al.
(2019)
(102) To assess adverse outcomes of EDs in
pregnancy, from 1st trimester to 6 months
postpartum. Assessment of covariates
(BMI, psychological factors, anxiety and
depressive symptoms)
To assess the association between EDs
and risk factors
Prospective longitudinal







assessed with the Eating
Attitudes Test-26
- Only smoking before pregnancy was associated with disordered
eating symptoms at the third trimester
- LGA and low Apgar score were more likely to have mothers with higher
levels of disordered eating at T2 and T3 (p < 0.01);
- SGA was more likely to have mothers with higher levels of disordered
eating at T2 (p < 0.005)
Sotodate
et al. (2019)
(103) To describe one possible fetal
consequences of maternal vitamin k
deficiency
2 cases reports The maternal subclinical
vitamin K deficiency due to
an ED could induce a fetal
intracranial hemorrhage
- EDs longer than 3 weeks could develop a maternal subclinical vitamin
K deficiency and, consequently, a fetal intracranial hemorrhage
- Pregnant women taking drugs inhibiting vitamin K metabolism or
intestinal absorption. It must be recommended to take vitamin K from














































































TABLE 4 | Comparison among studies on pregnancy and fetal outcomes.
Author. Ref. Type of study/N Pregnancy outcomes Fetal outcomes Strengths Limitations





Significantly lower cortisol decline in
women with current Eds (C-ED)
throughout the day
Lower cortisol decline among women
with a C-ED was associated with
higher levels of psychopathology
Infants’ stress response was
significantly higher among those in
the C-ED group
Inclusion of past and current
EDs
Small sample size




Micali et al. (89) Longitudinal cohort study
(ALSPAC) UK
AN = 171, BN = 199,
AN+BN = 82, others
ED = 1,166
n = 10,636 unexposed
Miscarriage in BN (OR 1,4 (95% CI
1.1–2.0), p < 0.05)
No differences in preterm delivery
SGA in AN women explained by low











Higher smoking in AN
Birth weight not adjusted
for GA
Blais et al. (83) Prospective study
N = 54
United States
High rate of therapeutic abortion in
EDs population











- Higher % of unplanned pregnancies
- Higher Ors for postnatal
depression, miscarriage, and
preterm delivery were 2.8 (95% CI,
1.2–6.2), 2.6 (95% CI, 1.2–5.6) and
3.3 (95% CI, 1.3–8.8), respectively,










active and past BN
Sollid et al. (85) Hospitalization records
Case-control prospective
study
(302 women with 504 births
vs. 900 women with 1,552
births)
Danish population
Greater risk of preterm delivery (OR,
1.7; 95% CI, 1.1-2.6) in women with
EDs
More incidence of Lower BW (OR,
2.2; 95% CI, 1.4–3.2), and SGA (OR,
1.8; 95% CI, 1.3–2.4) in ED
population
















Bulik et al. (91) MoBa study. Prospective
cohort (n = 35,929),
volunteered participation
(42%). Cases n = 2,187
ED in the 6-months prior to
or during pregnancy (AN
n = 35, BN n = 304, BED
n = 1,812, EDNOS-P
n = 36) Referent group (n
= 33,742)
- Preterm delivery adjusted by
gestational age, maternal age,
income, education, and parity:
- AN: OR 0.63 (95% CI: 0.091, 4.3)
p = 0.91
- BN: OR 0.78 (95% CI: 0.42, 1.4)
p = 0.88
- BED: OR 1.1 (95% IC: 0.92, 1.4)
p = 0.65 more C-section
BED had
- lower risk of SGA babies OR 0.65
(95% CI: 0.52, 0.8) p < 0.01, and
after adjusting by smoking OR 0.63
(95% CI 0.51, 0.79) p < 0.01
- More LGA OR 1.2 (95% CI: 1.1,
1.4), p = 0.02, and after adjusting
by smoking OR 1.2 (95% CI: 1.1,
1.4), p = 0.02
Large longitudinal sample
size
Strict diagnostic criteria for
EDs
Strict definition of SGA and
LGA
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ED = 122 (AN = 41BN = 62
EDNOS = 19) vs.
controls = 117,875
Israel
Eds were at risk of Preterm delivery
(OR 2.2, 95% CI 1.4–3.6) and
C-section (OR 1.9, 95% CI 1.3–2.9)









past and current EDs
Not adjusted for
confounding variables such
as social class and smoking
Inclusion of singleton and
multiple pregnancies
Bansil et al. (90) Retrospective
n = 1,668
United States
Eds were more associated to preterm
labor (OR 2.78, 95% CI 2.10–3.69),
anemia (OR 1.73, 95% CI 1.25–2.38),
genitourinary tract infections (OR
1.66, 95% CI 1.03–2.68), and labor
induction (OR 1.32, 95% CI
1.01–1.73)
More fetal growth restriction (odds












Franko et al. (84) Prospective study
Pregnant women with ED
(AN and BN) n = 49
United States
Pregnant women with EDs were at
greater risk for delivery by cesarean
section (41 vs. 12%) and for
postpartum depression (45 vs. 29%).
No differences in rates of prematurity
Higher rate of birth defects (n = 3,
6.1%)
No differences in rates of prematurity
Strict inclusion criteria for
EDs
Division in symptomatic and
non-syntomatic subgroups
Small sample size
Absence of control group
Micali et al. (61) Longitudinal
population-based birth
cohort




- Relative to unexposed women,
women with AN had a lower body
weight, regression coefficient −0.05
(95% CI −0.08 to −0.1) but a
higher rate of weight gain, 0.07%,
whereas women with BN had a
higher body weight (regression
coefficient 0.0007, 95% CI
0.00002–0.001) but a lower rate of
weight gain (regression coefficient
−0.0007, 95% CI −0.001 to
−0.0001)
- Maternal AN was positively
associated with fetal distress after
adjusting for confounders OR 1.8;
95% CI 1.0–3.1, p < 0.05. No
differences were found in mean
birthweight, prevalence of SGA or
premature birth. AN vs. BN vs.
AN+BN vs. unexposed BW 3.481 g
(480), 3,468 (575), 3,465 (586) vs.
3,439 (546) 0.8 vs. 4 vs. 2.1












- Main birth outcome measures in
women with a history of AN were
very similar to the main population
- Mean birthweight (g): AN 3,387 vs.
controls 3,431 g, p < 0.005.
Non-adjusted by sex and GA.
- Small for gestational age (adjusted
by sex and GA): no differences
-Discrete lower BW







Exclusion of ED outpatients
More severe EDs
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Koubaa et al. (82) Prospective case-control
Controls n = 68
Cases n = 49 (24 AN, 20
BN, 5 EDNOS)
Stockholm
- SGA: 12 vs. 1%, p < 0.005
- Low BW (g): AN 3,210 ± 533 vs.
controls 3,516 ± 515, p < 0.05.
- Head circumference (cm): AN 33.7
± 1.6, BN 33.7 ± 1.0, vs. controls
35.2 ± 1.6, both p < 0.001
- Microcephaly: ED 8% vs. controls
0%, p < 0.005
- IUGR: ED 8% vs. controls 0%, p
= 0.07
- GA (weeks): ED 38.9 ± 1.8 vs.
controls 39.2 ± 1.8, p = 0.043




High statistical power to
detect microcefaly
Small sample size
No differences beween past
or recent EDs
BW and head circumference
not adjusted for GA or sex
Linna et al. (51) Retrospective
EDs n = 2,257
Controls n = 9,028
Helsinki
- Women with BED were more than 3
times as likely to have a miscarriage
than controls (odds ratio (OR) 3.18;
95% confidence interval (CI)
1.52–6.66).
- Women with atypical BN, were
44% more likely to have a
miscarriage than controls (OR 1.44;
95% CI 1.02–2.04)




remission or continuation of
EDs
Linna et al. (95) Prospective case-control
population –based study
N = 7,379
Controls n = 6,319
Cases n = 1,078
(AN = 302, BN = 724,
BED = 52)
Helsinki
- AN was significantly associated
with anemia premature
contractions, very premature birth
(OR 4.59, 95% CI 1.25–16.87)
- BN was associated with premature
contractions (OR 2.2, 95% CI
1.17–4.14).
- BED was associated with maternal
hypertension (OR 4.32, 95% CI
1.64–11.36
AN and BN had significantly lower
BW babies (mean 3,302 g [SD 562],
adjusted p < 0.001 in AN, mean
3,464 g [563], adjusted p = 0.037 in
BN, mean 3,520 g [539] in
unexposed women)
- BED had higher weight babies
(mean 3812g [519], adjusted p
< 0.001). -AN was significantly
associated with slow fetal growth
(OR 2.59, 95% CI 1.43–4.71), small
for gestational age (OR 2.20, 95%
CI 1.23–3.93) and perinatal death
(adjusted OR 4.06, 95%
CI 1.15–14.35).
- BN was associated with
resuscitations of the neonate (OR
2.12, 95% CI 1.18–3.79), and a low
APGAR score (OR 2.31, 95%
CI 1.34–3.98)










to severity of ED















































































TABLE 4 | Continued
Author. Ref. Type of study/N Pregnancy outcomes Fetal outcomes Strengths Limitations
Watson et al. (99) Retrospective Cohort
N = 70,881 pregnancies in
grandmother-mother-child
triads. MoBa cohort
Controls (no ED) n = 65,586
Cases n = 5,295
(AN = 409, BN = 1,451,
BED = 3,362, Purging
disorder = 73).
- BN: Induced labor: RR 1.21 (95%
CI 1.07, 1.36)
- AN was associated with: low birth
weight (z-score): RR 0.74 (95% CI
0.68, 0.82). SGA: RR 1.54 (95% CI
1.09, 2.17). Postmature: RR 0.47
(95% CI 0.33; 0.67).
- BED: Birth weight (z-score): RR
1.07 (95% CI 1.05; 1.1). Length >
p90: RR 1.2 (95% CI 1.13; 1.28).










Micali et al. (97) Prospective case-control
N = 80,660
Controls n = 76,724
Cases n = 3,936 (AN 1,609,
BN 1,693, AN+BN 634)
UK
- Prematurity:
Active AN + past AN: not differences
on prematurity rates.
Active AN: double rates of prematurity
than past AN (7.51 vs. 4.11%).
Active AN increased rates prematurity
vs. controls (OR 1.77, 95% CI
1.00–3.12; p 0.049).
BN: not differences vs. controls
- IUGR: AN and AN+ BN: OR 1.6
[95% CI 1.3–1.8].
- SGA: AN and AN+BN: OR 1.5
[95% CI 1.2–1.9). AN (15.5%) vs.
controls (10.4%): OR 2.90 (95% CI
1.98–4.26). Lower birthweight was
more associated with active AN











Eik-nes et al. (100) Patient ED unit vs.
Population-based study
(The HUNT Study- Norway)
from clinical patient register
Cases = 532 Unexposed n
= 43,567
BN showed Higher rate of C- section
OR 1.7 95% CI 1.1–2.5





No adjustment for maternal
socioeconomic status, BMI
or smoking
Eagles et al. (93) Prospective case-control
matched (1 case: 5 controls)
by age, parity and year of
birth (1965–2007)
n = 804
Controls n = 670 women-
1,144 babies
Cases (AN) n = 134
women-−230 babies
Scotland










Koubaa et al. (67) Prospective case-control
N = 96
Controls n = 59
Cases n = 37 (AN 20, BN
17)
Stockholm
- Cortisol levels were comparable
between groups with the highest
mean value in the control group. In
the AN group only, there was a
positive correlation between cortisol
and head circumference of the
offspring at birth (rs = 0.49,
p < 0.05)
- Maternal serum levels of free
thyroxine were similar between
groups but correlated positively to
reduced head circumference at
birth of the children in the BN group
(r = 0.48, p < 0.05), and with the
same tendency in the AN group
(r = 0.42, p = 0.07), but not in the
controls (r = 0.006)
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- Serum levels of IGF-I SD-score
correlated positively with head
circumference of the offspring at
birth in the patient group (rs = 0.38,
p < 0.05) but not in the separate
groups
- However, in the combined patient
group, maternal free T4 correlated
positively to head circumference at
birth (rp = 0.36, p < 0.05), as in the
BN group (rp = 0.48, p < 0.05),
and with a similar tendency in the
AN group (rp = 0.42, p = 0.07)
- Head circumference (cm): AN 33.6
± 1.6, BN 33.8 ± 0.88, control
35.2 ± 1.6, both p < 0.005
O’Brien et al. (37) Prospective case-control,
cohort of sisters of women
with breast cancer
Controls n = 38,264
Eds n = 726
Puerto-Rican women
Miscarriage: OR 1.19 (95% CI
1.09–1.35)












Only smoking before pregnancy was
associated with disordered eating
symptoms at the third trimester (T3)
LGA and low Apgar score were more
likely to have mothers with higher
levels of disordered eating at the
second trimester (T2) and T3 (p
< 0.01); -SGA was more likely to
have mothers with higher levels of
























































Sebastiani et al. Eating Disorders During Gestation
of cesarean section in BN and BED groups. Other retrospective
study found similar results about the association between EDs
and obstetric complications with no links to cesarean section
(90). However, this study did not take into account confounding
factors such as smoking and socioeconomic status. Conversely,
Micali et al. (89) didn’t find any association between EDs and
preterm delivery although this study included a large longitudinal
community cohort with less severe disease.
Franko et al. (84) reported greater risk for cesarean birth and
postpartum depression in a group of women with AN and BN
but no differences in the rate of prematurity. The limitations of
these data were the absence of a control group, and the small
group size. Neither significant differences in preterm delivery
(61, 86), nor an increased risk of gestational diabetes (GD),
hypertension, pre-eclampsia, induction of labor, instrumental
delivery or postpartum bleeding were found in other prospective
population-based studies in EDs women.
One potential explanation for these inconsistent results may
be due to the inclusion criteria: in the population-based study,
participants required only self-reported ED, whereas many
clinical studies selected patients with EDs on the basis of
hospitalization and with a more actively ED. Moreover, GWG
improved faster in Norwegian and Dutch cohorts demonstrating
the concern and support by caregivers to EDwomen and thismay
explain the lack of adverse outcomes.
Recent studies found a strong causal association between
preterm delivery, fetal growth restriction, and low pre-pregnancy
BMI, malnutrition and a low proportion of weight gain
during pregnancy. This association remains after excluding
pathologies such as diabetes and hypertension (107). A recent
study conducted in a Norwegian population corroborated that
higher diet scores, reflecting healthy dietary behaviors in the
pre-pregnancy period and during pregnancy, prevent preterm
delivery (108). Maternal stress in pregnancy and consequential
high levels of CRH may also influence the timing of delivery
and this could elucidate the risk of preterm labor in women
with lifetime EDs (109). Furthermore, alteredmaternalmood and
anxiety may damage the intrauterine environment, enhancing
the risk of obstetric adverse outcomes (110, 111).
Although the association between EDs and poor obstetric
outcomes is multifactorial, the severe of disease, the persistence
of symptoms, low pre-pregnancy BMI and poor GWG, joined
with environmental factors such as social dysfunction, potential
stressors, smoking, drugs consumption and concomitant
psychiatric disorders may worsen pregnancy evolution. However,
a strong caregivers’ and psychological support may avoid
obstetric complication displaying normal pregnancy evolution.
Of note, a current ED increases the risk of adverse outcomes
during pregnancy more than a past ED (101).
The Impact of EDs on Fetal Outcomes (See
Tables 3, 4)
Available studies postulate the potential association between
maternal EDs symptoms during pregnancy and adverse fetal
outcomes. Fetal development is intrinsically linked to balanced
maternal nutrition, correct placental supply, and fetal growth
factors. Maternal malnutrition may affect fetal development
through the absence of nutrients, which are essential for fetal
growth, modifications of placental function, and epigenetic
changes in the fetal genome. Furthermore, maternal stressors
may alter the imprinting of fetal regulatory elements (112).
According to the theory of “early life programming,” an altered
intrauterine environment may predispose the offspring to the
risks of developing chronic diseases later in life (113).
Not all EDs types (AN, BN, BED, and ENDOS) have
been associated with the same fetal risks and not all studies
evaluated independently each type of ED. Therefore, the
conclusions obtained from the different studies and reviews are
not consistent.
Small for Gestational Age (SGA) and Intrauterine
Growth Restriction (IUGR)
Population-based studies have shown that neonates of pregnant
women with EDs are at higher risk of lower birth weight (BW)
than those of healthy pregnant women. Although they included
large sample size, one important limitation of these types of
studies was the classification of EDs based on self-reported
questionnaires. Furthermore, it is important to highlight that
a large number of studies did not use the proper definition of
SGA (weight percentile <10 adjusted for gender and gestational
age) to evaluate neonates. For example, the study of Micali et al.
(89) showed an association between AN and lower BW. This
large sample size includedmore than 1,600 pregnant women who
were classified as EDs with psychiatric disorders (n = 1,166),
BN (n = 199) AN (n = 171), and AN+BN (n = 82). The data
was adjusted by parity, maternal age, and smoker habits but the
proper definition of SGA was not applied. The study of Watson
et al. (99) also found a strict association between EDs and low BW
and concluded that maternal EDs increase the risks of pregnant
and neonatal complications, even when there is a correction for
perinatal outcomes in the previous generation. In a similar line,
Micali et al. (97) observed a higher odds of SGA (defined as
birthweight <10th percentile) in both AN and BN (OR 1.6, 95%
CI 1.3–1.8; OR 1.5, 95% CI 1.2–1.9, respectively) being more
associated with active AN than with past AN.
Furthermore, longitudinal prospective studies conducted
in Danish, Swedish, and Norwegian populations among
hospitalized pregnant women diagnosed with ED according to
strict criteria reported a higher incidence of low BW and SGA
(82, 85, 95, 100). However, the women included in these studies
were hospitalized, so they represented the most severe cases. The
main limitation of Kouba’s study (82) was the reduced sample
size and the lack of differentiation between past or current ED.
The main limitation of the study of Eik-nes et al. (100) was that,
although they registered smoking and socioeconomic status,
they did not consider these data to adjust the results. Recent
systematic reviews (27, 28, 87, 94) supported these findings
indicating that EDs are associated with low BW.
Conversely, other studies conducted in pregnant women with
a clinical diagnosis of EDs, did not find differences in the
association among EDs and low birth weight or the incidence
of SGA (84, 86). Nevertheless, these studies included women
who required hospitalization, and pregnant patients were strictly
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monitored and consequently this may reduce the number and
severity of perinatal complications. Moreover, the study of
Franko et al. (84) did not include a control group and Ekeus
et al. did not report GWG, which could be a protective factor for
impaired fetal growth.
With regard to IUGR, several studies corroborated the higher
incidence in pregnant women with EDs, if compared to general
population. Bansil et al. (90) analyzed a retrospective cohort
of pregnant women with 1,668 cases of strictly classified EDs,
observing an increased risk of IUGR (OR 9.08 95% CI 6.45–
12.77). However, in this study the outcomes were not adjusted
for maternal BMI, neither for confounding factors such as
maternal comorbidities, tobacco habit, substance misuses and
socioeconomic status. Eagles et al. (93) found similar conclusions
in a case-control study with a larger sample size evaluating
pregnant women with a clinical diagnosis of AN (134 cases),
adjusting the results for confounding factors such as maternal
BMI, smoking, and social class. Indeed, Kouba et al. (82) did not
find those differences, but the study was conducted in a small
sample size.
Therefore, we can state that generalization of these results is
limited because of the diversity of study designs, the inclusion
of different populations with wider range of severity, or small
sample sizes. Nonetheless, updated literature endorses the
notion that EDs during pregnancy may increase the risk of
having a baby with low BW or SGA. The severity of EDs
and an active ED have been associated with more risk of
IUGR. Moreover, the strongest relationship between EDs and
low BW was found in patients with low pre-pregnancy BMI
and/or low GWG. In the aforementioned studies, the mean
maternal body mass index was lower in the exposed than
in the unexposed group. Smoking, also may interact in the
delivery of low BW babies. Nevertheless, the majority of such
studies didn’t stratified their results for BMI categories and
few studies reported GWG or nutritional status of the mother
(89, 95, 99).
Large for Gestational Age (LGA)
Two case-control studies, both with more than 1,500 cases of
EDs, concluded that pregnant women with an ED (BED subtype)
had a higher risk of having LGA neonates (91, 99). Even more,
they showed a strong association between BN or BED and
gestational diabetes, which may clarify the greater incidence of
LGA. Watson et al. (99) also found in BED patients a high
incidence of neonates with length over the 90th percentile. The
main weakness of these studies were that ED diagnosis was self-
reported and in the study of Watson et al. statistical analysis was
not adjusted for possible confounder factors (99).
The studies by Linna et al. (95) and Watson et al. (99) also
showed that pregnancies in women with BED were more likely to
be prolonged. However, they did not obtain the same magnitude
of estimated risk (95, 99).
Additionally, a recent research found that women with BED
had higher intake of saturated fat during pregnancy, which may
explain the relationship between BED and larger size of newborns
(56). Women with BED were also found to gain more gestational
weight during pregnancy, affecting the fetal size (61).
Perinatal Mortality and Lower Apgar Score
Few data evaluated Apgar score and perinatal mortality in
women with EDs reporting contrasting results so there is a
lack of evidence to state that EDs is a risk factor for perinatal
morbidity and mortality. In the case-control study of Linna
et al. (95) neonates of pregnant women with BN exhibited
lower Apgar at minute one and they needed more resuscitation
in delivery room, but the most severe cases with binge and
purge episodes were included in this study, increasing the
risk of bias. Conversely, in the cohort of patients with EDs
studied by Franko et al. (84), no differences were found in
the Apgar score according to the diagnosis of AN or BN in
pregnant women. However, this study was performed in a small
sample size (only 49 EDs patients) and the results must be
interpreted carefully because ED groups were not compared to
a control group.
Regarding perinatal mortality, the case-control study of Eagles
et al. (93) did not report increased risk in neonates of pregnant
women with AN, but the study was conducted in a specific
population with higher GWG which may mitigate the poor
outcomes associated to EDs. Nevertheless, in the literature, the
relationship between perinatal mortality and EDs has been widely
reviewed (30, 87). Therefore, newborns of pregnant women with
EDs are at risk of perinatal mortality if compared to general
population. The relapse and exacerbation of ED symptoms




Two case-control studies showed lower head circumference
and a higher incidence of microcephaly in neonates of
pregnant women with EDs. Kouba et al. (82) were the
first to describe this notion, considering that it could be
due to high levels of maternal cortisol produced by stress,
especially in pregnant women with AN who had a BMI <20.
Another subsequent study by Koubaa et al. (67) concluded
that neonates of primiparous and no smoking pregnant women
with EDs, showed better head circumferences, even with the
same serum levels of thyroxin, a hormone which correlated
positively to head circumference. The authors concluded that,
in pregnant women with AN, there was a correlation between
maternal cortisol levels and neonatal cephalic perimeter. In
three previous reviews on the fetal repercussions of maternal
EDs, a correlation with lower head circumference was found;
however, these results were observed in small sample sizes,
and in the most severe ED patients but not in larger studies
(27, 28, 87).
With regard to congenital malformations the reviews of Park
et al. (30) and Newton et al. (87) stated that children of pregnant
women with EDs showed increased incidence, but these reviews
included previous studies dating back in 80’s and 90’s. Only
Newton et al. detailed that these malformations were cleft lip and
cleft palate (87).
Eight cases of prenatal intraventricular hemorrhage have
been described, attributable to maternal vitamin K deficiency
secondary to poor intake, or intestinal malabsorption. Placental
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transfer of vitamin K is scarce, and it is estimated that its
concentration in cord blood is 1/30 with respect to maternal
plasma levels, so a severe deficiency has been found in
malnourished mothers (103).
Therefore, actually the link among EDs during pregnancy and
microcephaly or malformations need more controlled studies to
corroborate it, including the correction for several confounding
factors such as maternal drugs, alcohol misuse, smoking, or
severe maternal malnutrition.
Possible Causes for Poor Fetal Outcomes
Some studies tried to find a positive association between mothers
with EDs and adverse pregnancy outcomes, impaired fetal
growth, malformations, and poor prognosis in their offspring.
In accordance with the theory of “fetal programming,” the
nexus between nutrition and stress in pregnant women with
EDs triggers the activation of maternal and fetal HPA axis,
increasing levels of maternal CRH (96). As consequence,
higher levels of glucocorticoids in fetal circulation have an
impact on fetal programming and neural development, and
are associated with low birth weight (114, 115). Smoking
is frequent in AN patients, linked to the desire to control
weight and appetite. Nicotine release appetite suppressors in
the brain (serotonin, dopamine, and norepinephrine), which
are also associated with impaired fetal growth (102, 115). In
addition, the use of laxatives, diuretics, and appetite suppressants
have been described to cause possible teratogenic complications
(85). If nutritional deficiencies such as low iron or folate
levels, low fish intake which is a source of iodine, L-PUFA
and vitamins are mixed with maternal stressors, the risk
of neural tube defects (67, 115), small head circumference
and impaired cognitive development increases (116, 117).
Furthermore, thyroid function and IGF-1 axis, essential for
fetal growth, may be compromised in pregnant women with
EDs (67).
The inconsistent of several studies is probably due to the
difference in the severity of illness between the clinical vs.
the population-based sample, finding a stronger association of
poor perinatal outcomes among the most severe cases of EDs.
Moreover, the presence of confounding factors were not taken
into account in some studies, such as maternal age, severe
psychiatric pathology, maternal BMI, or toxic habits like tobacco,
drugs, or alcohol. Furthermore, the majority of the studies didn’t
differentiate between past or active EDs.
Epigenetic Modifications: Association With
EDs and Nutritional Deficits During
Pregnancy (See Table 5)
Barker’s hypothesis defines fetal programming as the process
of fetal adaptation to the environmental conditions during
development (113). Therefore, EDs or a specific nutritional
deficiency during pregnancy produce severe alterations
in maternal and fetal epigenetic profiles (124). Epigenetic
mechanisms as the DNA methylation of CpG islands, the
Histone tail modifications by enzymes as well as the expression
control by microRNAs regulate the genomic imprinting,
modulating cellular differentiation and organogenesis during
fetal development (125).
Different nutrients are able to influence and modify these
processes and therefore the epigenetic pattern, in the mother
and the fetus during pregnancy, which is the most sensitive
period to epigenetic changes that will persist in adult life
(126). Micronutrients such as folic acid, choline, methionine,
and vitamin B12 are involved in the folate pathway. The
synthesis of methionine provides the methyl groups to DNA
methyltransferases DNMTs1,3a, and 3b as well as Histone
methyltransferases (HMTs), necessary for the global regulation
of gene expression. Therefore, a deficit of one of these
bioactive compounds alters the pattern of gene expression during
development (127, 128). For this reason, the diet of pregnant
women is always supplemented with folic acid (129). Moreover,
antioxidants such as polyphenols, present in fruits like grapes
and vegetables, green tea (EGCG), genistein, and curry, act
by inhibiting DNMTs. These enzymes control the levels of
oxidative stress, which negatively influences the metabolic profile
during fetal development, predisposing the fetus to pathogenic
alterations (130, 131).
Maternal malnutrition has been linked to epigenetic
alterations such as the methylation (silencing) of the IGF2 gene,
a key growth factor in fetal development (123). Higher levels
of methylation in genes related to hepatic and cardiac function
(CACNA1C and PDE1A related to intracellular calcium balance),
inflammation (IL10, IL6), lipid/carbohydrate metabolism such
as ABCA1 (related to cholesterol homeostasis), LEP (which
regulates the synthesis of leptin that controls body weight), and
GNASAS (which regulates hormonal metabolism) also appear
associated with suboptimal maternal nutrition (132, 133). In
accordance with Barker’s hypothesis, other studies indicate that
maternal malnutrition generates precocious insulin resistance
which may accelerate early postnatal growth by shifting toward
body fat instead of muscle mass (134). Some studies have
associated DNA methylation in obesity markers with infant
adiposity. Godfrey et al. (135) found a positive association
between high methylation levels of RXRα and NOS3 genes in
umbilical cord cells and adiposity in infants. On the other hand,
a maternal high-fat diet present in BN and BED correlates to the
origin of other metabolic diseases as hypertension and diabetes
through changes in the hypothalamic region. A diet rich in
fats also modifies the methylation status and the expression of
genes related to the mesocorticolimbic reward circuit (dopamine
and opioids) (136). Hyper-methylation of Leptin receptor,
melanin-concentrating hormone receptor 1 (MCHR1), and
proopiomelanocortin (POMC) was also related to an increase
in body mass index (BMI) and a higher risk of obesity (137),
also modifying energy homeostasis in the offspring (138). The
permanent deregulation of the hypothalamic circuits promotes
resistance to insulin and leptin, generating an increase in
overweight status and food intake.
Other genes silenced by a high-fat diet and recently related
to obesity are FYN (a member of the Src family of non-
receptor tyrosine kinase related to inflammation, adipocyte
differentiation, and insulin signaling), TAOK3 (an activator of
the protein kinase MAPK cascade which affects fundamental





























TABLE 5 | Studies about the effects of eating disorders on epigenome.
Author (year) References Aim of study Type of study.
Population
Epigenetic changes Key results





To study candidate genes










There are differences in the methylation pattern
between patients with anorexia and controls in
whole blood samples
SNCA gene promoter is hypermethylated in
anorexia patiens
Global DNA hypomethylation in women with
anorexia nervosa
DNA hypermethylation of the alpha synuclein
promoter
No differences in the global methylation status of
women with bulimia
Frieling et al. (2010) (119) To study candidate genes
which expression or
methylation pattern are










SLC6A3/DAT, DRD2, and DRD4 genes were
analized in whole blood samples of anorexia and
bulimia patients
No methylation differences were observed for DRD4
SLC6A3/DAT and DRD2 are hypermethylated in
patients with AN
In women with BN SLC6A3/DAT is
also hypermethylated
Ehrlich et al. (2012) (120) To study candidate genes
which expression or
methylation pattern are








POMC gene was analized in whole blood samples
of anorexia patients
No methylation differences were observed
Steiger et al. (2013) (121) To study candidate genes
which expression or
methylation pattern are
altered in women with







GR gen was analized in whole blood samples of
bulimia patients
No methylation differences were observed









There are differences in the methylation pattern
between patients with anorexia and controls in
whole blood samples
Global DNA hypomethylation in women with
anorexia nervosa













Methylation at the H19 DMR decreased in infants
born to women reporting folic acid intake compared
to infants born to women with no folid acid intake
during pregnancy
The use of folic acid during pregnancy is associated
with hypomethylation in the DNA sequence
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cellular signaling pathways), PIWIL4 (a regulator of adipocyte
proliferation) (139), and SIRT1 (expression stimulates the
metabolism of fats in adipocytes by suppressing the Peroxisome
proliferator-activated receptor PPARγ, also participating in the
regulation of glucose homeostasis, anti-inflammatory activity
and oxidative stress) (140). Therefore, a maternal diet rich in
fat decreases the expression of SIRT1 in the fetal liver and
heart, altering the fetal metabolism and generating a tendency to
increase body fat.
Nutritional deficits associated with low protein intake typical
of AN patients show harmful effects on fetal growth and
a higher risk of obesity, diabetes, and hypertension in the
offspring. These effects are caused by a deficit of folic acid,
choline, and methionine. The deficiency of gestational proteins
generates: hypomethylation of the Wnt2 promoter in the
placenta associated with fetal growth alterations (141); decreased
expression of IGF-I and IGF-II producing hyperglycemia (142);
hypermethylation of the PPARγ and Glucocorticoid receptor
(GR) promoters involved in the regulation of blood pressure and
in the metabolism of lipids in adults (143); increased expression
of angiotensin II which generates an increase in blood pressure
(142) and decreased expression of the agtr1b gene involved
in hypertension.
A maternal protein-restricted diet during pregnancy is also
associated with hypermethylation of key adipogenesis genes such
as the peroxisomal proliferator-activated receptor-α (PPAR-α)
related to cardiomyopathy in the offspring and liver X-receptor
promoter (LXR)α involved in glucose homeostasis in the fetal
liver (144). In addition, diets with protein deficits regulate
the expression of microRNA related to chronic inflammation
in offspring (145), as well as the over-expression of the
transcription factor C/EBPs (CCAAT-enhancer-binding protein)
which regulates the expression of genes involved in energy
homeostasis (146).
In the gene-environment interactions, the extreme nutritional
conditions associated with EDs such as AN, BN, and BED,
have been deeply studied in the pregnancy period, because
these disorders alter the epigenetic pattern of the mother
and the developing fetus (147). Several studies postulated
that environmental factors that favor thinness can lead to
the overexpression of genes that suppress appetite and/or
reduce body weight in individuals that are already genetically
susceptible to low BMI and reduced percentages of body fat.
When the complete genome methylation status is considered,
instead of specific promoter regions of candidate genes, patients
with anorexia and also patients with bulimia show a clear
hypomethylation in their epigenome compared to healthy
controls (118, 122). This phenomenon is produced by the
deficit of folate and methionine, with a consequent decrease
in the activity of DNMTs and HMTs, low protein intake,
and very low levels of glucose and cholesterol in the blood
(148). A recent study performed in 21 active ED, 43 past ED
and 126 controls concluded that offspring of women with an
active restrictive ED during pregnancy showed lower global
methylation pattern in their genome compared to offspring of
women with past restrictive ED. This study also demonstrated
a decreased methylation at the DHCR24 locus in offspring of
women with active ED during pregnancy and an increased
methylation at the LGALS2 locus in offspring of women with past
ED compared to controls (149).
Some differences in the expression of genes related to
dopamine metabolism have been observed in patients with
anorexia. An increase in the expression of the dopamine
transporter SLC6A3 and a decrease by hypermethylation of the
dopamine receptor D2 (DRD2) promoter have been associated
with the reward effect in individual diagnosed with AN (119).
Along the same line, the hypermethylation of the POMC
gene, a key regulator of appetite, and also the oxytocin
receptor gene OXTR, negatively associated with BMI, has been
observed in patients with AN (120). Moreover, a decrease in
the mRNA levels of the glucocorticoid receptor gene NR3C1
has also been observed in the anorexic population (121). Finally,
maternal psychosocial stress may alter placental imprinted gene
expression, and lead to suboptimal fetal growth (150).
Other environmental factors such as smoking, alcohol,
and drugs of abuse, which show higher percentages of
consumption in ED patients than general population (151–
153) may promote alterations in the epigenetic pattern of
the mothers diagnosed with ED and their offspring (154).
In a cohort of 40 patients diagnosed with EDs, Ehrlich
et al. demonstrated than the methylation state of the Pro-
opiomelanocortin (POMC) promoter was negatively affected by
smoking but it was not influenced by the nutritional status
(120). The co-occurrence of smoking and ED modify the
epigenome during pregnancy affecting fetal development. A
Recent study determined the effect of smoking during pregnancy
in the hypomethylation of the Aryl hydrocarbon receptor
repressor gene (AHRR) observed in neonates (155). Moreover,
prenatal alcohol exposure produces severe impairments in fetal
development which can result in fetal alcohol spectrum disorders
(FASD). Alcohol can alters one carbon metabolism, critical
for methylation of DNA, directly inhibiting the key enzymes
methylenetetrahydrofolate reductase (MTHFR) and methionine
synthase (MTR) (156, 157). Furthermore, recent studies have
demonstrated in prenatal alcohol exposed children a differential
methylation pattern in the genes SLC6A3 and DRD4 related to
the dopaminergic system; in HLADPB1 and CD11A related to
the immune response; and in H19 and SLC22A18 genes (158–
160).
It is important to mention that some of the hormonal
imbalances observed in EDs patients, as high cortisol and low
sex hormones levels, can be promoted by environmental factors
and they can influence the dynamics of the gene expression.
These hormones can behave as direct ligands to promoters or key
regulators which interact with transcription factors, altering the
expression pattern of the epigenome (161, 162).
A large amount of epigenetic studies has focused on AN
whereas the studies about BN are less abundant, and, in the
case of BED, there are only few publications in human subjects.
Additionally, most of these studies have small sample sizes, so it
is necessary to perform studies on a larger scale to confirm these
results. Finally, EDs are mainly brain disorders, so that some
epigenetic alterations are specific of the nervous tissue. However,
the majority of the published studies are performed using saliva





























TABLE 6 | Studies about comorbid psychopathology among pregnant women with eating disorders.
Author (year) References Aim of study Type of study. Population Key results
Franko et al. (2001) (84) To report pregnancy complications and
neonatal outcomes for 49 live births in a
group of women with eating disorders
Longitudinal n = 49 34.7% of women experienced postpartum depression
Mazzeo et al. (2006) (163) To investigate the associations among
eating disorders, depressive symptoms
during pregnancy and postpartum(PPD)
and perfectionism in a population-based
sample of women
Twin-based study n = 1,119 BN (OR 3.5, 95% confidence interval [95% CI].
1.3–9.6) and BED (OR 2.8, 95% CI 1.1–7.0) diagnoses were strongly
associated with PPD symptoms as assessed by the screening item.
However, AN was not (OR 1.3, 95% CI 0.51–3.3).
Koubaa et al. (2008) (164) To study early adaptation to motherhood





92% of mothers with EDs before pregnancy reported problems
regarding their maternal adjustment compared to 13% in the control
group (p < 0.001), whereas there were no differences between the
subgroups of ED and between those with and without verified relapse
of ED during pregnancy.
50% of mothers with previous ED reported that they had been in
contact with health services after delivery because of depression or
other mental problems
The exact odds ratios after adjustment for depression:
25 (95% CI 2.4-infinity) for AN of restrictive type,
31 (95% CI 5.4–341) for AN of binge eating type,
116 (95% CI 17-infinity) for BN
(p < 0.01, p < 0.001, and p < 0.001, respectively)
Micali et al. (2011) (165) To investigate the effect of past
depression, past and current eating
disorders (EDs) on perinatal anxiety and
depression in a large general population
cohort of pregnant women
Longitudinal Cohort
n = 10,887
Past-ED with (n = 123) and without past
depression (n = 50), pregnancy ED
symptoms with (n = 77) and without past
depression
(n = 159), past depression only (n = 818)
and controls (n = 9,660).
Women with a history of EDs had increased levels of anxiety and
depression during the antenatal and postnatal periods. This was most
marked in the group with pregnancy ED symptoms and past
depression (b coefficient:5.1 (95% CI: 4.1–6.1), pb 0.0001), especially
at 8 months post-partum
Meltzer-Brody et al. (2011) (166) To examine the prevalence of comorbid
eating disorders (EDs) and trauma history
in women with perinatal depression.





Women with BN reported more severe depression during perinatal
period.
BN: EPDS score, 19.1, standard deviation [SD 4.3], p = 0.02;
PHQ-severity 14.5, SD 7.4, p = 0.02
Controls: EPDS score 13.3, SD = 6.1; PHQ 9.0, SD = 6.2)
Easter et al. (2015) (167) To investigate longitudinal patterns of
psychopathology during the antenatal and
postnatal periods among women with
current and past ED
Observational prospective
Current ED
(C-ED) n = 31
Past ED
(P-ED) n = 29
Controls n = 57
- Women with a C-ED at the start of pregnancy showed an overall
pattern for decreasing levels of psychopathology among the antenatal
and postnatal periods.
- Symptoms of ED: C-ED (b coeff: 1.3,95% CI: 1.1–1.5) and P-ED
groups (b coeff: 0.6, 95% CI: 0.4–0.8) had higher total EDE-Q scores
compared with healthy controls
- Anxiety: C-ED and P-ED had higher state (C-ED = b coeff: 0.5, 95%
CI: 0.4–0.7; P-ED = b coeff: 0.3, 95% CI:0.1–0.4) and trait (C-ED = b
coeff: 0.5, 95% CI: 0.4–0.6; P-ED = b coeff: 0.2, 95% CI: 0.1–0.4)
anxiety scores, compared with healthy controls
- Depression C-ED (b coeff: 2.0, 95% CI: 1.5–2.6) and P-ED (b coeff:



















































Sebastiani et al. Eating Disorders During Gestation
or blood samples, which is a limitation to take into account for
future studies.
EDs During Pregnancy and Maternal
Psychopathology (See Table 6)
Comorbid emotional disorders are common in women with
EDs who typically experience depression, anxiety, or obsessive
compulsive disorder (168). Recent evidence shows higher rates
of depression and anxiety throughout pregnancy and during the
postpartum period in women with active EDs related to their
shape and weight concern (88, 89). Moreover, childbirth may
trigger or relapse the onset of a comorbid psychiatric illness in
the mother. Altered mood may impair the normal course of
pregnancy and fetal development leading to adverse perinatal
outcomes such as prematurity, SGA and IUGR babies (110).
Furthermore, the post-partum period is the one at highest risk
for worsening a depressive disturbance, particularly in women
with an ED (84, 166), because infant feeding, maternal-child
bonding, and the desire of weight loss, may exacerbate ED
symptoms and lead to a mood disorder. Maternal adjustment
during the first 3 months after delivery was clearly impaired
and related to mental disturbances in mothers with EDs before
pregnancy (164). Misuse of alcohol at conception, lower BMI,
higher frequency of binging after delivery, and a history of AN,
increased the risk of post-partum depression symptoms (169).
Easter et al. (167) investigated longitudinal patterns of
psychopathology during the antenatal and postnatal periods
among womenwith current and past EDs. They found decreasing
levels of psychopathology at the start of pregnancy in women
with current ED. However, symptoms of anxiety, and depression
remained high at all pregnancy stages. In contrast women
with a past ED were at risk of increasing psychopathology
throughout pregnancy and during the postnatal period. The
strengths of this data were the longitudinal design and the
strict inclusion criteria of EDs, but the main limitation was
the small sample with insufficient power to detect potential
differences. Mazzeo et al. (163) assessed the association among
EDs, depressive symptoms, and perfectionism during pregnancy
or post-partum in a population-based sample of pregnant
women. This data showed a higher rate of depressive symptoms
during pregnancy and post-partum in women with a history
of EDs, in particular in women with BN and BED, and the
authors found a relationship between symptoms of depression
and aspects of perfectionism. One limitation of this study was
the lack of information regarding the timing of the beginning
of the depressive symptoms and the diagnostic criteria of post-
partum depression. Along the same line, Micali et al. (165)
investigated the effect of past depression, and past or current ED,
on perinatal anxiety and depression in a large general population
cohort of pregnant women. They found that women with a
history of an ED had increased levels of anxiety and depression
during the antenatal and postnatal periods. ED symptoms and
past depressive episodes were related to the highest risk for a
depressive and anxiety disorder during pregnancy. Data was
limited to a self-reported assessment of psychiatric history. One
possible explanation of these results is that women with EDs are
predisposed to develop an affective disorder and this condition
together with the stressful stage of pregnancy, aggravated by
body image concern, weight gain, and loss of control, may
trigger a psychiatric illness (28). Another possible reason may
be associated with nutritional deficiencies, for example zinc
deficiency has been linked to depression symptoms (58). Low
levels of micronutrients like folate, vitamin D, vitamin B12,
iron, selenium, and fatty acids, which are essential for the
biosynthesis of several neurotransmitters (serotonin, dopamine,
and norepinephrine) have been linked to perinatal depression
(170). Furthermore, elevated levels of cortisol described in
patients with EDs have been associated with most forms of
depression (171).
The Effects of EDs on Postpartum Course,
Breastfeeding, and the Composition of
Human Milk
Kouba et al. (164) described that women with EDs had more
problems regarding their adjustment to the new maternal
situation at 3 months post-partum. Although the prevalence
of postpartum remission was high, EDs continued in a large
proportion of women and, in the postpartum period, women
with EDs experienced a decrease in BMI during the first 6 months
after delivery (65).
If the onset of EDs was before pregnancy the proportion
remitting was significantly low. The presence of binge symptoms
or compensatory behaviors during pregnancy, expressed a more
severe form of BN, which persisted in the postpartum period.
Higher BMI and psychological dysfunction were associated with
continuation of BED during postpartum (172). Furthermore, a
retrospective case-control study demonstrated that a third of
women with EDs developed postnatal depression increasing the
risk for relapse of EDs (88).
Some studies showed an increased rate of breastfeeding
among women with current or prior EDs related to the
motivation and the desire for weight loss, while other studies
found low incidence (20, 165). Nevertheless, mothers with active
or paste EDs reported problems when giving human milk, such
as scarce lactation and precocious finalization of breastfeeding
(46). Torgersen et al. (173) conducted a large population-based
study and reported that women with EDs started breastfeeding in
the same proportion as women without EDs. However, women
with EDs were more likely to stop breastfeeding earlier than
the control group. Women with BED had a lower rate of
lactation. A possible explanation was that women with EDs felt
embarrassment when breastfeeding and they showed high shape
dissatisfaction and lower self-esteem. Moreover, they had low
social support and felt depressed when breastfeeding. Stress has
also been related to the short duration of lactating period (174).
Low leptin levels in ED patients could influence the capacity to
regulate the mechanisms of satiety in breastfed infants, leading
to lactation failure (175). Squires et al. (176) showed that ED
women were likely to have less mother-infant interaction during
feeding. They described that such mothers were less sensitive
when feeding their babies, more stressed, and with dysregulated
interaction patterns.
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To our knowledge there is a lack of studies regarding the
composition of human milk in ED patients. A recent study
described that the variance inmilk fat content has been associated
with BMI, and maternal body composition may be related to
the nutritional value of human milk (177). We may speculate
that mothers with an ED have low pre-pregnancy nutritional
status that can lead to low maternal fat stores for lactation,
and low nutritional amounts for the baby. For example, lower
iron and vitamin B12 intake in mothers with an ED may cause
deficiency of these elements in breastfed infants with consequent
neurological disabilities (178). Moreover, lowmaternal vitaminD
status described in AN patients may affect vitamin D quantities
received by the breastfed neonate (179).
EDs During Pregnancy: Risk Factors and
Psychological Intervention
Themost important risk factors linked to the onset of EDs during
pregnancy are: (24, 102) personality characterized by low self-
esteem and perfectionism; mood disorders such as depression,
anxiety and obsessive-compulsive disorder; a history of social
dysfunction, maltreatment or sexual abuse; toxic consumption
like smoking, drugs of abuse and alcohol; inadequate or
excessive stres; greater BMI changes from pre-pregnancy period;
unplanned pregnancy and lower marital and social support. The
major risk factor is a past history of EDs or family history of
EDs (180).
Psychological intervention focused on symptoms of dietary
restriction and overevaluation of shape and weight, helps
the patients to establish a pattern of regular eating, avoid
compensatory behaviors and reducing dieting in order to address
motivation (181).
Nevertheless, there is a lack of clinical trials about
psychological intervention in pregnant women with EDs.
The treatment includes Cognitive Behavioral Therapy (CBT)
and Interpersonal Psychotherapy (IPT) which have been used as
treatments for prenatal and postnatal depression demonstrating
potential benefits but it is difficult to know which is the most
effective (14, 182). The goal is to maintain regular eating patterns
and optimize nutritional intake for the mother and fetus (183)
The body of evidence supporting IPT use is far more modest
than it is for CBT (184). CBT reached higher rates of remission
in patients with BN and BED (185).
EDs During Pregnancy: Target Therapy
Based on current evidence pregnancy is a critical period for an
intervention in EDs women which should be strictly monitored
prior, during, and after pregnancy. Nonetheless, there are
several challenges for clinicians. The best approach for pregnant
women with EDs implies a multidisciplinary management
comprised of gynecologists, midwives, nutritionists, and mental
health professionals working as a team. However, there is an
insufficient medical training to openly discuss eating behaviors
with the patient (29). Women with EDs do not often disclose
this information to clinicians due to fear of stigmatization
or misunderstanding. Some questionnaires are applied to ED
identification, but none of them are specific to pregnant
population. UK guidelines (NICE) suggest asking one or two
specific questions. The SCOFF questionnaire has been also
proposed (6). Recently, Emery et al. reported a structured clinical
interview to assess disordered eating patterns among overweight
and obese pregnant women [The Eating Disorder Examination
Pregnancy Version (EDE-PV)] (186). Identifying women with
EDs but with normal weight is still more difficult.
Otherwise pregnant women with EDs show a specific
nutritional patterns: many of them are vegetarian (or with
a lower intake of meat), they smoke and consume high
amounts of coffee and do not show significant deficiencies in
mineral and vitamins (60). Moreover, dietary supplements are
similar between pregnant women with and without EDs (187).
Therefore, pregnant women with EDs should receive accurate
information from a dietitian about a balanced diet involving food
from each nutritional group correctly represented and also about
daily energy requirements, not only during pregnancy, but also
during post-partum and breastfeeding (80).
It is also important to mention that the use of psychotropic,
analgesic, and gastrointestinal medication should be assessed
(188). AN or recurrent self-induced purging in the absence
of binge eating (EDNOS-P) was directly associated with the
use of anxiolytics and sedatives post-partum (adjusted RR:
5.11, 99% CI: 1.53–17.01 and adjusted RR: 6.77, 99% CI:
1.41–32.53, respectively). The use of analgesics was higher in
pregnant women with BED, and laxatives were also used by
all women with EDs, before, during, and after pregnancy. In
severe cases of BN, antidepressant medication could be needed.
The most common are selective serotonin reuptake inhibitors
(SSRIs) (14). Clinicians should be encouraged to query about
patients’ medication and provide evidence-based counseling
about the risks of treatment exposure vs. the risks of untreated
psychiatric diseases.
DISCUSSION (TABLE 7)
The incidence of EDs has increased globally in the last years,
particularly in developed countries. These disturbances start at
an early age in adolescent girls due to the social pressure about
body shape stereotypes and the impact of beauty canons showed
in social programs or mass media. Slimness reflects healthy
nutritional habits if it is not associated with self-destructive
behaviors, emotional dysregulation, excessive pursuit of thinness,
and restrictive and bulimic eating patterns, typical of EDs.
The combination of body changes during puberty, anxiety, and
psychological disorders may trigger the first episodes of vomiting
and purging, becoming into pathologically dysfunctional eating
behaviors (55).
Stress and anxiety may play a critical role in the onset of
EDs. Binges and purging episodes are described more likely to
happen in response to environmental stressors. Stress promotes
long-term maladaptive modifications in neural circuits that
regulate food intake, included neuroendocrine and sympathetic
pathways (189).
Patients present a deficit in emotion regulation abilities
in response to an acute psychosocial stressor (190). Stress
itself may complicate the course of pregnancy and can cause
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TABLE 7 | EDs during pregnancy: bullets points.
Periconceptional period • High rate of unplanned pregnancy
• Infertility




• Micronutrients and vitamin deficiencies
• Anemia, leukopenia, trombocytopenia
• Low mineral density
Nutritional profile during
pregnancy
• Similar dietary patterns to general population
• High diet quality score in ED population (more
vegetarian)
• BED: greater intake of total energy and fat
• Higher amount of caffeine
• Greater risk for gestational anemia
• Higher risk of micronutrient deficiencies
GWG • GWG depends on the relapse of ED symptoms
during pregnancy
• Lower GWG in hospitalized patients if compared
to general population
Endocrine manifestations • Hypotalamic and pituitary dysfunction
• Suppressed thyroid function
• Low leptin and peptide YY levels, high ghrelin levels
• Increase insulin sensitivity, high adiponectin levels
• High cortisol and CRH levels
Pregnancy outcomes Increased risk of:
• Spontaneous abortion and preterm delivery
• BED y BN: greater rate of C-section
Fetal outcomes Increased risk of:
• IUGR
• SGA
• LGA (BED subtype)
• Perinatal mortality (few studies)
• Microcephaly and intraventricular hemorrhage
(few studies)
Maternal psychopatology • Depression
• Anxiety
• Post-partum depression
Postpartum period • Depression
• Stress
• Earlier stop of breatsfeeding
preterm deliveries or intrauterine growth restriction, regardless
the diagnosis of ED (191).
Women with EDs may display severe malnutrition, leading
to hypothalamic dysfunction, low bone mass and precocious
osteopenia (44, 62). Moreover, patients with AN have been
found to have at least one vitamin and trace element deficiencies
suggesting an alteration of micronutrient status (71).
In this line diet is one of the most important factors during
pregnancy, which may program the health of the offspring.
Therefore, unbalanced diet may predispose the developing
fetus to several diseases in adulthood as the demand of
macro and micronutrients increases during pregnancy (192–
195). Furthermore, a malnutrition status as well as alterations
in hormonal pathways may reduce but no abolish fertility in
ED women, leading to an insufficient use of contraception and
therefore producing a high incidence of unplanned pregnancy.
This condition promotes an additional risk of impaired fetal
development due to the lack of concern about prenatal
care (abstinence from alcohol, no smoking, multivitamin
supplements, and balanced nutrition) (42).
Pregnancy represents a period of increased vulnerability,
which may trigger dysfunctions on the eating patterns or may
be a chance to improve and treat EDs due to the concern
for the unborn baby and a different perception of body image
during gestation.
Our systematic review displays a global overview
about the impact of EDs during pregnancy explaining its
multifactorial mechanisms.
Patients with EDs show adverse pregnancy outcomes such as
miscarriage, preterm delivery, or fetal disabilities as poor fetal
growth or malformations. However, the multifactorial origin
of EDs as well as the limited experimental studies performed
in humans make difficult to establish a clear relationship
between EDs during pregnancy and birth impairments. Maternal
malnutrition and poor GWG suggesting a relapse of EDs
symptoms alter the fetal supply of nutrients and trigger the
deregulation of several hormonal pathways, increasing the risk
of damage to intrauterine environment. An altered nutritional
pattern in mothers, also induce epigenetic changes in the global
expression pattern of the fetus, which will trigger biological
and psychological alterations in offspring lifelong outcomes.
Additionally, substances of abuse such as alcohol, narcotics, or
tobacco, more frequent in EDs patients, may have a comorbid
impact on fetal development. These environmental factors also
produce changes in the global pattern of gene expression as
well as hormonal imbalances. So that, they represent some of
the multifactorial variables that strongly influence the epigenetic
profile of the mothers with EDs and their offspring.
Considering the evidence that previous and most severe EDs
are at the highest risk of fetal impairment, it is imperative to
detect altered eating patterns in childbearing age women during
the pre-conception period. Once diagnosed, a multidisciplinary
team have to start the treatment for the specific ED detected,
which includes nutritional support, a screening related to alcohol
and drugs of abuse, psychotherapeutic techniques, and the use of
psychotropics if necessary. Early detection is essential to prevent
malnutrition, mental and somatic comorbidities, and the relapse
of symptoms during gestation with consequent poor obstetric
and fetal outcomes. An early intervention will empower the
woman to her own care and would avoid lifelong morbidity for
both mother and fetus.
The present study has been performed following the
PRISMA methodology for systematic reviews and the authors’
clinical experience.
However, some of the studies explored in this review show
opposite results probably because they investigated different
populations with different health conditions: for example,
hospitalized patients with severe EDs vs. a sample of general
populations with self-reported EDs.
An important bias in the majority of the papers evaluated was
the diagnosis of maternal EDs by self-reported screening and the
dietary intake through a food frequency questionnaire. The main
limitations of these questionnaires were the different food lists
and the possible mistakes in self-reporting. Moreover, the self-
reporting method for determining the inclusion criteria of EDs
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usually underestimate their prevalence as well as some important
features such asmental mood, GWG, and nutritional status of the
mother. Otherwise the fetal adverse outcomes have multifactorial
causes, so a combination of several comorbid disorders may
impair fetal development such as undernutrition, psychiatric
pathologies, or substance abuse besides EDs. Moreover, a large
number of studies did not distinguish between past or active EDs
and several studies did not adjust for confounding factors such as
smoking, drugs, pre-conception maternal BMI or the severity of
the illness, generating biases.
Pregnant ED patientsmay display a good gestational evolution
if they reach a healthier BMI preceding pregnancy, a correct
GWG, a balanced nutrition, and a healthy mental state of
the mother.
Nevertheless, the recognition of dysregulated eating patterns
is a challenge for clinicians due to the lack of a standardized
screening method during pregnancy. EDs impair gastrointestinal
function leading to esophageal acidic damage for self- inducing
vomiting, gastric distension, dysphagia, increased intestinal
motility and chronic diarrhea. Clinician should detect
such symptoms and practice the differential diagnosis with
intestinal disease like celiac disease, gastroesophageal reflux, and
inflammatory bowel diseases (196).
Clinicians have to be alert to recognize the psychological
features associated with the onset of EDs during gestation,
reinforcing the positive changes of body image in pregnant
women and focusing on self-nurturing interventions
to reduce stress and anxiety (15). Clinicians have also
to motivate pregnant women to supplement essential
nutrients such as iron, folate, and iodine for an adequate
fetal development.
This target intervention must be continued in the postpartum
period, which is the most vulnerable stage for the relapse of
EDs symptoms and for the overlap with psychiatric disorders.
Mothers with EDs also experience stress during the breastfeeding
period, therefore a strict postpartum follow-up is necessary.
Finally, it is also necessary to clarify the biological mechanisms
that promote harmful effects on the fetus of mothers diagnosed
of EDs. Further prospective studies with large sample sizes
are needed, discriminating the consequences of the different
subtypes of EDs. Human trials would also determine appropriate
approaches to treat these disorders in order to design structured
interventions during gestation.
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